Page last updated: 2024-08-03 13:17:53
peptones
Description
Peptones: Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. (Dorland, 28th ed) [MeSH]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 42552953 |
| MeSH ID | M0016245 |
Synonyms (8)
| Synonym |
|---|
| 73049-73-7 |
| peptones |
| dimethyl (3,3-diethylbutyl)malonate |
| (3,3-diethylbutyl)malonic acid dimethyl ester |
| 1020253-71-7 |
| hy soy |
| dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate |
| soypeptone |
Research
Studies (1,580)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 969 (61.33) | 18.7374 |
| 1990's | 133 (8.42) | 18.2507 |
| 2000's | 211 (13.35) | 29.6817 |
| 2010's | 215 (13.61) | 24.3611 |
| 2020's | 52 (3.29) | 2.80 |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 29 (1.71%) | 5.53% |
| Reviews | 17 (1.00%) | 6.00% |
| Case Studies | 1 (0.06%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 1,647 (97.23%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| ethylene dichloride | | chloroethanes | hepatotoxic agent;
mutagen;
non-polar solvent | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| provitamin c | | hexose | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| acetic acid | | monocarboxylic acid | antimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent | 2001 | 2022 | 15.7 | low | 0 | 0 | 0 | 5 | 0 | 1 |
| acetaldehyde | | aldehyde | carcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| acetamide | | acetamides;
carboximidic acid;
monocarboxylic acid amide;
N-acylammonia | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| acetoin | | methyl ketone;
secondary alpha-hydroxy ketone | metabolite | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| acetone | | ketone body;
methyl ketone;
propanones;
volatile organic compound | EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent | 1970 | 1974 | 52.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| adenine | | 6-aminopurines;
purine nucleobase | Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1963 | 2003 | 46.0 | low | 0 | 2 | 0 | 1 | 0 | 0 |
| ammonium hydroxide | | azane;
gas molecular entity;
mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant | 1964 | 2023 | 34.8 | low | 0 | 10 | 2 | 3 | 3 | 1 |
| arsenic acid | | arsenic oxoacid | Escherichia coli metabolite | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| benzene | | aromatic annulene;
benzenes;
volatile organic compound | carcinogenic agent;
environmental contaminant;
non-polar solvent | 1990 | 2006 | 26.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| benzoic acid | | benzoic acids | algal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| betaine | | amino-acid betaine;
glycine derivative | fundamental metabolite | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| bromide | | halide anion;
monoatomic bromine | | 1971 | 1972 | 52.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| butyric acid | | fatty acid 4:0;
straight-chain saturated fatty acid | human urinary metabolite;
Mycoplasma genitalium metabolite | 2014 | 2015 | 9.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| formic acid | | monocarboxylic acid | antibacterial agent;
astringent;
metabolite;
protic solvent;
solvent | 1964 | 2009 | 37.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| catechol | | catechols | allelochemical;
genotoxin;
plant metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| methane | | alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound | bacterial metabolite;
fossil fuel;
greenhouse gas | 1974 | 2022 | 18.2 | low | 0 | 1 | 1 | 6 | 2 | 1 |
| choline | | cholines | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1946 | 1946 | 78.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| citric acid, anhydrous | | tricarboxylic acid | antimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite | 1984 | 2013 | 28.0 | low | 0 | 1 | 1 | 0 | 1 | 0 |
| chlorine | | halide anion;
monoatomic chlorine | cofactor;
Escherichia coli metabolite;
human metabolite | 1971 | 2012 | 33.0 | low | 0 | 2 | 1 | 0 | 1 | 0 |
| hydrochloric acid | | chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride | mouse metabolite | 1959 | 2011 | 44.9 | low | 0 | 10 | 3 | 0 | 1 | 0 |
| 4-vinylguaiacol | | phenols | flavouring agent;
pheromone;
plant metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| gallic acid | | trihydroxybenzoic acid | antineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| octanoic acid | | medium-chain fatty acid;
straight-chain saturated fatty acid | antibacterial agent;
Escherichia coli metabolite;
human metabolite | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| hydrogen sulfide | | gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride | Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent | 1958 | 1975 | 58.8 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| guaiacol | | guaiacols | disinfectant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
expectorant;
plant metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| aminocaproic acid | | amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid | antifibrinolytic drug;
hematologic agent;
metabolite | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cytosine | | aminopyrimidine;
pyrimidine nucleobase;
pyrimidone | Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1969 | 1973 | 53.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| lactic acid | | 2-hydroxy monocarboxylic acid | algal metabolite;
Daphnia magna metabolite | 1947 | 2022 | 17.8 | low | 0 | 1 | 2 | 7 | 5 | 2 |
| diacetyl | | alpha-diketone | Escherichia coli metabolite;
Saccharomyces cerevisiae metabolite | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| dihydroxyacetone | | ketotriose;
primary alpha-hydroxy ketone | antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dimethyl sulfoxide | | sulfoxide;
volatile organic compound | alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger | 1971 | 1973 | 52.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| ethanolamine | | ethanolamines;
primary alcohol;
primary amine | Escherichia coli metabolite;
human metabolite;
mouse metabolite | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| formaldehyde | | aldehyde;
one-carbon compound | allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1958 | 1989 | 55.8 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| glycine | | alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical | 1967 | 2017 | 41.6 | low | 0 | 11 | 0 | 3 | 2 | 0 |
| glycerol | | alditol;
triol | algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent | 1963 | 2023 | 35.1 | low | 0 | 24 | 1 | 9 | 9 | 1 |
| hydrogen carbonate | | carbon oxoanion | cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1968 | 2006 | 41.6 | low | 1 | 6 | 1 | 1 | 0 | 0 |
| histamine | | aralkylamino compound;
imidazoles | human metabolite;
mouse metabolite;
neurotransmitter | 1946 | 2010 | 51.4 | low | 0 | 40 | 9 | 2 | 0 | 0 |
| hydrogen | | elemental hydrogen;
elemental molecule;
gas molecular entity | antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite | 1964 | 2022 | 24.8 | low | 0 | 4 | 1 | 7 | 4 | 1 |
| hydrogen | | elemental hydrogen;
elemental molecule;
gas molecular entity | antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite | 1964 | 2022 | 25.8 | low | 0 | 4 | 1 | 7 | 3 | 1 |
| indole | | indole;
polycyclic heteroarene | Escherichia coli metabolite | 1982 | 1982 | 42.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| iodine | | diatomic iodine | nutrient | 1954 | 1976 | 59.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| dihydroxyphenylalanine | | hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative | human metabolite | 1969 | 1972 | 53.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| 2,3,4,5-tetrahydroxypentanal | | hydroxyaldehyde;
pentose;
polyol | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| thioctic acid | | dithiolanes;
heterocyclic fatty acid;
thia fatty acid | fundamental metabolite;
geroprotector | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| methanol | | alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound | amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| methanol | | alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound | amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite | 2006 | 2008 | 17.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| phytic acid | | inositol phosphate | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| inositol | | cyclitol;
hexol | | 1967 | 2007 | 43.2 | low | 0 | 4 | 0 | 1 | 0 | 0 |
| acetanilide | | acetamides;
anilide | analgesic | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| naphthalene | | naphthalenes;
ortho-fused bicyclic arene | apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component | 2010 | 2023 | 7.5 | low | 0 | 0 | 0 | 1 | 0 | 1 |
| nickel | | metal allergen;
nickel group element atom | epitope;
micronutrient | 1991 | 2006 | 25.5 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| niacinamide | | pyridine alkaloid;
pyridinecarboxamide;
vitamin B3 | anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor | 1974 | 1984 | 46.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| niacin | | pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3 | antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nitrates | | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | | 1964 | 2021 | 34.9 | low | 0 | 17 | 1 | 11 | 4 | 1 |
| nitrites | | monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species | human metabolite | 1966 | 2020 | 35.8 | low | 0 | 5 | 1 | 2 | 1 | 0 |
| orotic acid | | pyrimidinemonocarboxylic acid | Escherichia coli metabolite;
metabolite;
mouse metabolite | 1964 | 1997 | 45.7 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| oxalic acid | | alpha,omega-dicarboxylic acid | algal metabolite;
human metabolite;
plant metabolite | 1952 | 2023 | 36.5 | low | 0 | 1 | 0 | 0 | 0 | 1 |
| 4-aminobenzoic acid | | aminobenzoic acid;
aromatic amino-acid zwitterion | allergen;
Escherichia coli metabolite;
plant metabolite | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| parathion | | C-nitro compound;
organic thiophosphate;
organothiophosphate insecticide | acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
mouse metabolite | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phenanthrene | | ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes | environmental contaminant;
mouse metabolite | 2008 | 2023 | 10.2 | low | 0 | 0 | 0 | 1 | 2 | 1 |
| phenol | | phenols | antiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| phenylpyruvic acid | | 2-oxo monocarboxylic acid | chromogenic compound;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
fundamental metabolite | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phosphoenolpyruvate | | carboxyalkyl phosphate;
monocarboxylic acid | fundamental metabolite | 1972 | 1975 | 50.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| prephenic acid | | oxo dicarboxylic acid | Escherichia coli metabolite;
plant metabolite | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 1-propanol | | propan-1-ols;
short-chain primary fatty alcohol | metabolite;
protic solvent | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| purine | | purine | | 1964 | 1964 | 60.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| pyridoxine | | hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6 | cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1969 | 1984 | 48.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| pyruvic acid | | 2-oxo monocarboxylic acid | cofactor;
fundamental metabolite | 1964 | 2016 | 24.5 | low | 0 | 1 | 2 | 1 | 2 | 0 |
| thiosulfates | | divalent inorganic anion;
sulfur oxide;
sulfur oxoanion | human metabolite | 1964 | 2013 | 31.5 | low | 0 | 1 | 2 | 0 | 1 | 0 |
| selenic acid | | selenium oxoacid | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| selenious acid | | selenium oxoacid | | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfites | | divalent inorganic anion;
sulfur oxide;
sulfur oxoanion | | 1952 | 2009 | 52.0 | low | 0 | 10 | 0 | 1 | 0 | 0 |
| succinic acid | | alpha,omega-dicarboxylic acid;
C4-dicarboxylic acid | anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent | 2006 | 2010 | 16.3 | low | 0 | 0 | 0 | 3 | 0 | 0 |
| taurine | | amino sulfonic acid;
zwitterion | antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite | 1969 | 2018 | 20.5 | low | 0 | 1 | 0 | 0 | 3 | 0 |
| thiamine | | primary alcohol;
vitamin B1 | Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1964 | 1984 | 52.3 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| thymine | | pyrimidine nucleobase;
pyrimidone | Escherichia coli metabolite;
human metabolite;
mouse metabolite | 1968 | 1975 | 52.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| toluene | | methylbenzene;
toluenes;
volatile organic compound | cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| uracil | | pyrimidine nucleobase;
pyrimidone | allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite | 1963 | 1971 | 56.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| urea | | isourea;
monocarboxylic acid amide;
one-carbon compound | Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1950 | 2020 | 36.5 | low | 0 | 8 | 2 | 3 | 3 | 0 |
| 1-anilino-8-naphthalenesulfonate | | aminonaphthalene;
naphthalenesulfonic acid | fluorescent probe | 1963 | 2022 | 34.6 | low | 0 | 11 | 1 | 4 | 4 | 1 |
| mercaptoethanol | | alkanethiol;
primary alcohol | geroprotector | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| oxyquinoline | | monohydroxyquinoline | antibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator | 1965 | 2015 | 34.0 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| amobarbital | | barbiturates | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| acetovanillone | | acetophenones;
aromatic ketone;
methyl ketone | antirheumatic drug;
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| aspirin | | benzoic acids;
phenyl acetates;
salicylates | anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent | 1986 | 1995 | 33.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| caffeine | | purine alkaloid;
trimethylxanthine | adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic | 1967 | 2003 | 40.3 | low | 0 | 2 | 0 | 1 | 0 | 0 |
| verapamil | | aromatic ether;
nitrile;
polyether;
tertiary amino compound | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| camostat | | benzoate ester;
carboxylic ester;
diester;
guanidines;
tertiary carboxamide | anti-inflammatory agent;
anticoronaviral agent;
antifibrinolytic drug;
antihypertensive agent;
antineoplastic agent;
antiviral agent;
serine protease inhibitor | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| chlorpromazine | | organochlorine compound;
phenothiazines;
tertiary amine | anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug | 1963 | 1968 | 59.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| cimetidine | | aliphatic sulfide;
guanidines;
imidazoles;
nitrile | adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor | 1980 | 1985 | 41.5 | low | 2 | 2 | 0 | 0 | 0 | 0 |
| cystamine | | organic disulfide;
primary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| deferoxamine | | acyclic desferrioxamine | bacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore | 1968 | 1986 | 47.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| valproic acid | | branched-chain fatty acid;
branched-chain saturated fatty acid | anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| epirizole | | aromatic ether | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| famotidine | | 1,3-thiazoles;
guanidines;
sulfonamide | anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor | 1991 | 1997 | 30.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| fluconazole | | conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug | environmental contaminant;
P450 inhibitor;
xenobiotic | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| fluorouracil | | nucleobase analogue;
organofluorine compound | antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| gabexate | | benzoate ester | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| guanethidine | | azocanes;
guanidines | adrenergic antagonist;
antihypertensive agent;
sympatholytic agent | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| hexamethonium | | quaternary ammonium salt | | 1958 | 1958 | 66.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| indomethacin | | aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole | analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic | 1987 | 1987 | 37.0 | low | 2 | 2 | 0 | 0 | 0 | 0 |
| 2-propanol | | secondary alcohol;
secondary fatty alcohol | protic solvent | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| kojic acid | | 4-pyranones;
enol;
primary alcohol | Aspergillus metabolite;
EC 1.10.3.1 (catechol oxidase) inhibitor;
EC 1.10.3.2 (laccase) inhibitor;
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor;
NF-kappaB inhibitor;
skin lightening agent | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| lansoprazole | | benzimidazoles;
pyridines;
sulfoxide | anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| lorglumide | | benzamides;
dicarboxylic acid monoamide;
dichlorobenzene;
glutamic acid derivative | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| vitamin k 3 | | 1,4-naphthoquinones;
vitamin K | angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| methantheline | | xanthenes | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nocodazole | | aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes | antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ethylmaleimide | | maleimides | anticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nalidixic acid | | 1,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic | antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor | 1974 | 1976 | 49.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| omeprazole | | aromatic ether;
benzimidazoles;
pyridines;
sulfoxide | | 1983 | 2000 | 31.2 | low | 3 | 1 | 4 | 0 | 0 | 0 |
| 4-chlorophenol | | monochlorophenol | | 2005 | 2023 | 14.0 | low | 0 | 0 | 0 | 3 | 0 | 1 |
| patulin | | furopyran;
gamma-lactone;
lactol | antimicrobial agent;
Aspergillus metabolite;
carcinogenic agent;
mutagen;
mycotoxin;
Penicillium metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pd 98059 | | aromatic amine;
monomethoxyflavone | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| phenazine | | azaarene;
heteranthrene;
mancude organic heterotricyclic parent;
phenazines;
polycyclic heteroarene | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| phenolsulfonphthalein | | 2,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone | acid-base indicator;
diagnostic agent;
two-colour indicator | 1989 | 1989 | 35.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phenoxybenzamine | | aromatic amine | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| pirenzepine | | pyridobenzodiazepine | anti-ulcer drug;
antispasmodic drug;
muscarinic antagonist | 1980 | 1989 | 39.4 | low | 5 | 8 | 0 | 0 | 0 | 0 |
| potassium chloride | | inorganic chloride;
inorganic potassium salt;
potassium salt | fertilizer | 1969 | 1992 | 46.3 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| 4-aminobenzoic acid | | aminobenzoate;
aromatic amino-acid anion | Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| probenecid | | benzoic acids;
sulfonamide | uricosuric drug | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| proglumide | | benzamides;
dicarboxylic acid monoamide;
glutamine derivative;
racemate | anti-ulcer drug;
cholecystokinin antagonist;
cholinergic antagonist;
delta-opioid receptor agonist;
drug metabolite;
gastrointestinal drug;
opioid analgesic;
xenobiotic metabolite | 1990 | 1990 | 34.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| propranolol | | naphthalenes;
propanolamine;
secondary amine | anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic | 1967 | 2002 | 35.5 | low | 0 | 2 | 1 | 1 | 0 | 0 |
| rabeprazole | | benzimidazoles;
pyridines;
sulfoxide | anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor | 2000 | 2000 | 24.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| sulfadiazine | | pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic | 1965 | 1974 | 53.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| sulfadimethoxine | | aromatic ether;
pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
antimicrobial agent;
drug allergen;
environmental contaminant;
xenobiotic | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfamethoxazole | | isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| sulfamethoxypyridazine | | pyridazines;
sulfonamide antibiotic;
sulfonamide | antiinfective agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfaphenazole | | primary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfisoxazole | | isoxazoles;
sulfonamide antibiotic;
sulfonamide | antibacterial drug;
drug allergen | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate | | trihydroxybenzoic acid | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| tranexamic acid | | amino acid | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| tripelennamine | | aromatic amine | | 1949 | 1949 | 75.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| urethane | | carbamate ester | fungal metabolite;
mutagen | 1966 | 1971 | 55.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| w 7 | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| prednisolone | | 11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone | adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| reserpine | | alkaloid ester;
methyl ester;
yohimban alkaloid | adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cephaloridine | | beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative | antibacterial drug | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phentolamine | | imidazoles;
phenols;
substituted aniline;
tertiary amino compound | alpha-adrenergic antagonist;
vasodilator agent | 1986 | 2002 | 28.3 | low | 0 | 1 | 1 | 1 | 0 | 0 |
| sorbitol | | glucitol | cathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent | 1964 | 2023 | 36.4 | low | 0 | 5 | 0 | 1 | 0 | 1 |
| thymidine | | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite | 1973 | 1984 | 47.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| hydroxyproline | | 4-hydroxyproline;
L-alpha-amino acid zwitterion | human metabolite;
mouse metabolite;
plant metabolite | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| carbachol | | ammonium salt;
carbamate ester | cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic | 1981 | 2000 | 30.8 | low | 0 | 1 | 4 | 0 | 0 | 0 |
| estrone | | 17-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols | antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| pilocarpine | | pilocarpine | antiglaucoma drug | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| triiodothyronine | | 2-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine | human metabolite;
mouse metabolite;
thyroid hormone | 2010 | 2011 | 13.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| alanine | | alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite | 1965 | 1973 | 55.7 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| serine | | L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1965 | 2002 | 48.3 | low | 0 | 8 | 1 | 1 | 0 | 0 |
| benz(a)anthracene | | ortho-fused polycyclic arene;
tetraphenes | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| chloramphenicol | | C-nitro compound;
carboxamide;
diol;
organochlorine compound | antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor | 1963 | 2009 | 45.9 | low | 0 | 15 | 2 | 1 | 0 | 0 |
| aspartic acid | | aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
mouse metabolite;
neurotransmitter | 1965 | 2008 | 48.0 | low | 0 | 6 | 0 | 1 | 0 | 0 |
| glutamine | | amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite | 1975 | 2014 | 30.8 | low | 0 | 2 | 0 | 1 | 1 | 0 |
| lysine | | aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid | algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1964 | 1984 | 52.6 | low | 0 | 9 | 0 | 0 | 0 | 0 |
| cyanides | | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor | 1966 | 2018 | 41.0 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| sucrose | | glycosyl glycoside | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent | 1965 | 2023 | 28.6 | low | 0 | 18 | 2 | 12 | 10 | 3 |
| sucrose | | glycosyl glycoside | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent | 1965 | 2023 | 28.3 | low | 0 | 18 | 2 | 13 | 10 | 3 |
| tubocurarine | | bisbenzylisoquinoline alkaloid | drug allergen;
muscle relaxant;
nicotinic antagonist | 1967 | 1968 | 56.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| 9,10-dimethyl-1,2-benzanthracene | | ortho-fused polycyclic arene;
tetraphenes | carcinogenic agent | 1976 | 1979 | 46.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| aminopyrine | | pyrazolone;
tertiary amino compound | antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic | 1976 | 1976 | 48.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 2,3,4,6-tetrachlorophenol | | tetrachlorophenol | xenobiotic metabolite | 2005 | 2023 | 12.8 | low | 0 | 0 | 0 | 3 | 1 | 1 |
| uridine | | uridines | drug metabolite;
fundamental metabolite;
human metabolite | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| kanamycin a | | kanamycins | bacterial metabolite | 1971 | 1974 | 52.2 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| galactose | | D-galactose;
galactopyranose | Escherichia coli metabolite;
mouse metabolite | 1970 | 2023 | 44.8 | low | 0 | 10 | 0 | 1 | 0 | 1 |
| phenylephrine | | phenols;
phenylethanolamines;
secondary amino compound | alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| levodopa | | amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid | allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug | 2017 | 2019 | 6.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| edetic acid | | ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid | anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector | 1973 | 2002 | 38.0 | low | 0 | 3 | 2 | 1 | 0 | 0 |
| phenylethyl alcohol | | benzenes;
primary alcohol | Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tyrosine | | amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical | 1964 | 2015 | 38.9 | low | 0 | 6 | 2 | 2 | 1 | 0 |
| methylene blue | | organic chloride salt | acid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer | 1971 | 1972 | 52.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| leucine | | amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1969 | 1982 | 49.7 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| methacholine chloride | | quaternary ammonium salt | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| aniline | | anilines;
primary arylamine | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dimethylnitrosamine | | nitrosamine | geroprotector;
mutagen | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| lactose | | lactose | | 1950 | 2018 | 39.8 | low | 0 | 20 | 1 | 3 | 4 | 0 |
| methionine | | aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid | antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical | 1964 | 2017 | 41.8 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| phenylalanine | | amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid | algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1964 | 2013 | 46.8 | low | 0 | 9 | 0 | 1 | 1 | 0 |
| desoxycorticosterone | | 20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone | human metabolite;
mouse metabolite | 1963 | 1969 | 57.8 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| colchicine | | alkaloid;
colchicine | anti-inflammatory agent;
gout suppressant;
mutagen | 1970 | 1982 | 48.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| gallamine triethiodide | | | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cycloheximide | | antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol | anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor | 1968 | 1991 | 49.0 | low | 0 | 8 | 1 | 0 | 0 | 0 |
| egtazic acid | | diether;
tertiary amino compound;
tetracarboxylic acid | chelator | 1991 | 2009 | 24.0 | low | 0 | 0 | 1 | 1 | 0 | 0 |
| chloroform | | chloromethanes;
one-carbon compound | carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant | 1960 | 1971 | 57.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| sodium citrate, anhydrous | | organic sodium salt | anticoagulant;
flavouring agent | 2011 | 2022 | 7.5 | low | 0 | 0 | 0 | 0 | 1 | 1 |
| cycloserine | | 4-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion | antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist | 1971 | 1974 | 51.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| ampicillin | | beta-lactam antibiotic;
penicillin allergen;
penicillin | antibacterial drug | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| mannitol | | mannitol | allergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent | 1963 | 2010 | 40.1 | low | 0 | 8 | 0 | 4 | 0 | 0 |
| ornithine | | non-proteinogenic L-alpha-amino acid;
ornithine | algal metabolite;
hepatoprotective agent;
mouse metabolite | 1968 | 1997 | 41.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| asparagine | | amino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1964 | 2008 | 50.2 | low | 0 | 11 | 0 | 1 | 0 | 0 |
| histidine | | amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite | 1967 | 2017 | 39.0 | low | 0 | 4 | 0 | 0 | 1 | 0 |
| 1,1,1-trichloroethane | | chloroethanes | polar solvent | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| isopropamide iodide | | diarylmethane | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| valine | | L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| threonine | | amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine | algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1964 | 1973 | 56.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| tryptophan | | erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan | antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite | 1966 | 2009 | 43.1 | low | 0 | 8 | 0 | 2 | 0 | 0 |
| isoleucine | | aspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| arginine | | arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid | biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical | 1965 | 2008 | 46.2 | low | 0 | 14 | 1 | 1 | 0 | 0 |
| ethylene | | alkene;
gas molecular entity | plant hormone;
refrigerant | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| methylamine | | methylamines;
one-carbon compound;
primary aliphatic amine | mouse metabolite | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| propane | | alkane;
gas molecular entity | food propellant | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| trichloroacetic acid | | monocarboxylic acid;
organochlorine compound | carcinogenic agent;
metabolite;
mouse metabolite | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| bromthymol blue | | 2,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
polyphenol;
sultone | acid-base indicator;
dye;
two-colour indicator | 1977 | 1989 | 41.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| tromethamine | | primary amino compound;
triol | buffer | 1964 | 1979 | 51.8 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| 1,1,2-trichloroethane | | chloroethanes | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| peracetic acid | | a peroxy acid | disinfectant;
oxidising agent | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pantothenic acid | | pantothenic acid;
vitamin B5 | antidote to curare poisoning;
geroprotector;
human blood serum metabolite | 1974 | 1974 | 50.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| taurocholic acid | | amino sulfonic acid;
bile acid taurine conjugate | human metabolite | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| quintozene | | aromatic fungicide;
C-nitro compound;
pentachlorobenzenes | antifungal agrochemical | 1996 | 1997 | 27.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| n-vinyl-2-pyrrolidinone | | pyrrolidin-2-ones | | 1967 | 2009 | 48.0 | low | 0 | 7 | 0 | 1 | 0 | 0 |
| thymol | | monoterpenoid;
phenols | volatile oil component | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| veratryl alcohol | | benzyl alcohols;
dimethoxybenzene;
primary alcohol | fungal metabolite | 1997 | 2012 | 19.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| nitrobenzene | | nitroarene;
nitrobenzenes | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| trehalose | | trehalose | Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1975 | 2007 | 31.3 | low | 0 | 1 | 1 | 1 | 0 | 0 |
| dicloran | | aromatic fungicide;
dichlorobenzene;
nitroaniline | antifungal agrochemical | 1986 | 1998 | 30.7 | low | 0 | 1 | 2 | 0 | 0 | 0 |
| 4-chloronitrobenzene | | C-nitro compound | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ethylbenzene | | alkylbenzene | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| caprolactam | | caprolactams | human blood serum metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cyanuric acid | | 1,3,5-triazinanes;
1,3,5-triazines;
heteroaryl hydroxy compound | xenobiotic | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| trinitrotoluene | | trinitrotoluene | explosive | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| framycetin | | aminoglycoside | allergen;
antibacterial drug;
Escherichia coli metabolite | 1965 | 1974 | 54.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| benzoin | | benzoins;
secondary alpha-hydroxy ketone | EC 3.1.1.1 (carboxylesterase) inhibitor | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2-tolidine | | biphenyls | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2,4-dichlorophenol | | dichlorophenol | | 2006 | 2016 | 13.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| vanillic acid | | methoxybenzoic acid;
monohydroxybenzoic acid | plant metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| meglumine | | hexosamine;
secondary amino compound | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 2-naphthol | | naphthol | antinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ethyl acetate | | acetate ester;
ethyl ester;
volatile organic compound | EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 3-o-methylglucose | | D-aldohexose derivative | | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cyclopentane | | cycloalkane;
cyclopentanes;
volatile organic compound | non-polar solvent | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| thiazoles | | 1,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene | | 1969 | 1987 | 46.0 | low | 1 | 2 | 0 | 0 | 0 | 0 |
| triphenyltetrazolium | | organic cation | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| calcium gluconate | | calcium salt | nutraceutical | 2005 | 2005 | 19.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| hydrazine | | azane;
hydrazines | EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| gamma-resorcylic acid | | dihydroxybenzoic acid | metabolite | 2010 | 2011 | 13.8 | medium | 0 | 0 | 0 | 3 | 1 | 0 |
| azacitidine | | N-glycosyl-1,3,5-triazine;
nucleoside analogue | antineoplastic agent | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| perfluorooctanoic acid | | fluoroalkanoic acid | carcinogenic agent;
endocrine disruptor;
environmental contaminant;
surfactant;
xenobiotic | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| perfluorodecanoic acid | | fluoroalkanoic acid | environmental contaminant;
xenobiotic | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| aminoimidazole carboxamide | | aminoimidazole;
monocarboxylic acid amide | mouse metabolite | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| methysergide | | ergoline alkaloid | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| citrulline | | amino acid zwitterion;
citrulline | Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite | 1971 | 1997 | 40.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| hydantoins | | imidazolidine-2,4-dione | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| methylguanidine | | guanidines | EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin | 1976 | 1976 | 48.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| limestone | | calcium salt;
carbonate salt;
inorganic calcium salt;
one-carbon compound | antacid;
fertilizer;
food colouring;
food firming agent | 1970 | 2015 | 33.9 | low | 0 | 4 | 0 | 1 | 2 | 0 |
| fusarium | | | | 1965 | 2020 | 35.4 | low | 0 | 7 | 2 | 2 | 2 | 0 |
| methyl red | | | | 1954 | 1954 | 70.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sodium carbonate | | carbonate salt;
organic sodium salt | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| podophyllotoxin | | furonaphthodioxole;
lignan;
organic heterotetracyclic compound | antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| gluconic acid | | gluconic acid | chelator;
Penicillium metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| copper gluconate | | organic molecular entity | | 1969 | 2017 | 41.2 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| n-hexadecane | | long-chain alkane | non-polar solvent;
plant metabolite;
volatile oil component | 2010 | 2014 | 12.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| magnesium carbonate | | carbonate salt;
magnesium salt;
one-carbon compound;
organic magnesium salt | antacid;
fertilizer | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| gentian violet | | organic chloride salt | anthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye | 1981 | 2006 | 26.7 | low | 0 | 1 | 0 | 2 | 0 | 0 |
| malachite green | | organic chloride salt | antibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent | 1991 | 1997 | 30.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| galactitol | | hexitol | Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phenylglyoxylic acid | | 2-oxo monocarboxylic acid | biomarker;
human xenobiotic metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| c.i. 42510 | | | | 1969 | 1997 | 38.3 | low | 0 | 1 | 2 | 0 | 0 | 0 |
| brilliant green | | organic hydrogensulfate salt | antibacterial agent;
antiseptic drug;
environmental contaminant;
fluorochrome;
histological dye;
poison | 1981 | 1989 | 39.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| erythromycin | | cyclic ketone;
erythromycin | | 1963 | 2011 | 37.0 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| nitrosoguanidines | | | | 1971 | 1975 | 51.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| 2,6-dichloroindophenol | | dichlorobenzene;
quinone imine | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| testolactone | | 3-oxo-Delta(1),Delta(4)-steroid;
seco-androstane | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ferrous sulfide | | | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| glycyrrhizic acid | | enone;
glucosiduronic acid;
pentacyclic triterpenoid;
tricarboxylic acid;
triterpenoid saponin | EC 3.4.21.5 (thrombin) inhibitor;
plant metabolite | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| pristane | | long-chain alkane;
norterpene | biomarker;
immunological adjuvant | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fucose | | fucopyranose;
L-fucose | Escherichia coli metabolite;
mouse metabolite | 1970 | 1971 | 53.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| 2,2-bis(bromomethyl)-1,3-propanediol | | primary alcohol | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| sabinene | | thujene | plant metabolite | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| mannose | | D-aldohexose;
D-mannose;
mannopyranose | metabolite | 1970 | 2022 | 43.0 | low | 0 | 5 | 0 | 0 | 0 | 1 |
| dithiothreitol | | 1,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol | chelator;
human metabolite;
reducing agent | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| azo rubin s | | | | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| streptomycin | | antibiotic antifungal drug;
antibiotic fungicide;
streptomycins | antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor | 1948 | 1978 | 56.0 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| carbonates | | carbon oxoanion | | 1969 | 2009 | 29.0 | low | 0 | 1 | 0 | 2 | 0 | 0 |
| carbenicillin | | penicillin allergen;
penicillin | antibacterial drug | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| dihydrostreptomycin sulfate | | | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| ammonium nitrate | | ammonium salt;
inorganic molecular entity;
inorganic nitrate salt | explosive;
fertilizer;
oxidising agent | 2014 | 2017 | 8.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| manganese | | elemental manganese;
manganese group element atom | Escherichia coli metabolite;
micronutrient | 1963 | 2019 | 40.1 | low | 0 | 6 | 1 | 2 | 1 | 0 |
| mercury | | elemental mercury;
zinc group element atom | neurotoxin | 1951 | 2012 | 37.4 | low | 0 | 2 | 1 | 1 | 1 | 0 |
| ruthenium | | iron group element atom;
platinum group metal atom | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| silver | | copper group element atom;
elemental silver | Escherichia coli metabolite | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| technetium | | manganese group element atom | | 1982 | 1982 | 42.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| tungsten | | chromium group element atom | micronutrient | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cadmium | | cadmium molecular entity;
zinc group element atom | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| chromium | | chromium group element atom;
metal allergen | micronutrient | 2006 | 2022 | 10.0 | low | 0 | 0 | 0 | 1 | 0 | 1 |
| gadolinium | | f-block element atom;
lanthanoid atom | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| gold | | copper group element atom;
elemental gold | | 2010 | 2019 | 8.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| uranium | | actinoid atom;
f-block element atom;
monoatomic uranium | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| magnesium sulfate | | magnesium salt;
metal sulfate;
organic magnesium salt | anaesthetic;
analgesic;
anti-arrhythmia drug;
anticonvulsant;
calcium channel blocker;
cardiovascular drug;
fertilizer;
tocolytic agent | 1970 | 2015 | 40.8 | low | 0 | 7 | 0 | 0 | 2 | 0 |
| acetylglucosamine | | N-acetyl-D-glucosamine | epitope | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| galactosamine | | D-galactosamine;
primary amino compound | toxin | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| phosphoric acid, trisodium salt | | sodium phosphate | | 2015 | 2017 | 8.0 | low | 0 | 0 | 0 | 0 | 3 | 0 |
| sodium nitrate | | inorganic nitrate salt;
inorganic sodium salt | fertilizer;
NMR chemical shift reference compound | 1997 | 2021 | 16.8 | low | 0 | 0 | 1 | 3 | 0 | 1 |
| hypochlorous acid | | chlorine oxoacid;
reactive oxygen species | EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
human metabolite | 2010 | 2014 | 11.7 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| camptothecin | | delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol | antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ferric chloride | | iron coordination entity | astringent;
Lewis acid | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ferrous sulfate | | iron molecular entity;
metal sulfate | reducing agent | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bromine | | diatomic bromine | | 1976 | 2013 | 29.5 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| zinc sulfate | | metal sulfate;
zinc molecular entity | fertilizer | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| potassium nitrate | | inorganic nitrate salt;
potassium salt | fertilizer | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| sodium sulfite | | inorganic sodium salt;
sulfite salt | food preservative;
reducing agent | 2009 | 2023 | 8.0 | low | 0 | 0 | 0 | 1 | 0 | 1 |
| magnesium phosphate (2:3) | | inorganic magnesium salt | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| copper sulfate | | metal sulfate | emetic;
fertilizer;
sensitiser | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| silver nitrate | | inorganic nitrate salt;
silver salt | astringent | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sodium thiosulfate | | inorganic sodium salt | antidote to cyanide poisoning;
antifungal drug;
nephroprotective agent | 1993 | 2000 | 27.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| potassium sulfate | | inorganic potassium salt;
potassium salt | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| deuterium | | dihydrogen | | 1974 | 2010 | 32.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| chlorine | | diatomic chlorine;
gas molecular entity | bleaching agent | 1976 | 2010 | 33.5 | low | 0 | 4 | 0 | 2 | 0 | 0 |
| deuterium oxide | | deuterated compound;
water | NMR solvent | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| galactose | | | | 1962 | 1975 | 56.2 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| hexadimethrine bromide | | | | 1953 | 1953 | 71.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ammonium ferric sulfate | | ammonium salt;
iron molecular entity;
metal sulfate | ferroptosis inducer | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| chlorine dioxide | | chlorine dioxide | | 2001 | 2001 | 23.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| rhamnose | | L-rhamnose | | 1971 | 1972 | 52.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| chloramine | | halide | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ammonium chloride | | ammonium salt;
inorganic chloride | ferroptosis inhibitor | 1971 | 2023 | 28.8 | low | 0 | 2 | 2 | 1 | 0 | 1 |
| tetrathionic acid | | sulfur oxoacid | | 1975 | 1987 | 43.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| cephalexin | | beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative | antibacterial drug | 1972 | 1998 | 39.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| tetradecanoylphorbol acetate | | acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester | antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fluorides | | halide anion;
monoatomic fluorine | | 1966 | 1966 | 58.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| chromium | | chromium cation;
monoatomic hexacation | | 2006 | 2022 | 10.0 | low | 0 | 0 | 0 | 1 | 0 | 1 |
| phenyl acetate | | benzenes;
phenyl acetates | | 1964 | 2017 | 37.8 | low | 0 | 10 | 0 | 5 | 2 | 0 |
| cetylpyridinium chloride anhydrous | | chloride salt;
organic chloride salt | antiseptic drug;
surfactant | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| methylformamide | | formamides | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| pyrene | | ortho- and peri-fused polycyclic arene | fluorescent probe;
persistent organic pollutant | 2023 | 2023 | 1.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| transferrin | | | | 1964 | 1991 | 44.4 | low | 0 | 4 | 1 | 0 | 0 | 0 |
| glutamic acid | | glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid | Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical | 1965 | 2015 | 25.5 | low | 0 | 2 | 0 | 2 | 2 | 0 |
| azides | | pseudohalide anion | mitochondrial respiratory-chain inhibitor | 1971 | 1974 | 51.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| iprodione | | benzenes;
dichlorophenyl dicarboximide fungicide;
imidazole fungicide;
imidazolidine-2,4-dione;
ureas | antifungal agrochemical;
nematicide | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| enkephalin, methionine | | | | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cefaclor anhydrous | | cephalosporin | antibacterial drug;
drug allergen | 2010 | 2011 | 13.5 | low | 1 | 0 | 0 | 1 | 1 | 0 |
| fomesafen | | aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols | agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide | 1966 | 1984 | 49.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| lovastatin | | delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring) | anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tzu 0460 | | piperidines | | 1987 | 1988 | 36.5 | low | 2 | 2 | 0 | 0 | 0 | 0 |
| loxiglumide | | organic molecular entity | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| adenosine | | adenosines;
purines D-ribonucleoside | analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent | 1976 | 1976 | 48.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ferric citrate | | iron chelate | anti-anaemic agent;
nutraceutical | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| vanadates | | trivalent inorganic anion;
vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| acridine orange | | aminoacridines;
aromatic amine;
tertiary amino compound | fluorochrome;
histological dye | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| potassium phosphate | | inorganic phosphate salt;
inorganic potassium salt | | 1991 | 2015 | 18.9 | low | 0 | 0 | 3 | 2 | 4 | 0 |
| caloreen | | | | 1975 | 2008 | 27.7 | low | 0 | 1 | 0 | 2 | 0 | 0 |
| trazodone hydrochloride | | hydrochloride | adrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor | 1968 | 2021 | 19.4 | low | 0 | 2 | 0 | 4 | 4 | 1 |
| glucose, (beta-d)-isomer | | D-glucopyranose | epitope;
mouse metabolite | 1978 | 2014 | 33.3 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| metaperiodate | | iodine oxoacid | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| surfactin peptide | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| 4-aminomethylbenzoic acid | | benzoic acids | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cephalosporin c | | cephalosporin | fungal metabolite | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| triazoles | | 1,2,3-triazole | | 1964 | 2012 | 36.0 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| delphinidin | | anthocyanidin chloride | | 1977 | 1980 | 45.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| ubiquinone-o | | ubiquinones | Escherichia coli metabolite;
human metabolite | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| mifentidine | | | | 1988 | 1988 | 36.0 | low | 1 | 1 | 0 | 0 | 0 | 0 |
| cresol red | | 2,1-benzoxathiole;
arenesulfonate ester;
polyphenol;
sultone | acid-base indicator;
dye;
two-colour indicator | 1989 | 1989 | 35.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| perfluorooctane sulfonic acid | | perfluoroalkanesulfonic acid | antilipemic drug;
persistent organic pollutant | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| 1-hydroxybenzotriazole | | benzotriazoles | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ethyl 2-cyanoacrylate | | | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| hypobromous acid | | bromine oxoacid | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| bromates | | bromine oxoanion;
monovalent inorganic anion | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| coenzyme a | | adenosine 3',5'-bisphosphate | coenzyme;
Escherichia coli metabolite;
mouse metabolite | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nicotine | | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic | 1964 | 1971 | 56.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| fibrinogen | | iditol | fungal metabolite | 1964 | 1979 | 54.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| goethite | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| glycidyl nitrate | | | | 1995 | 2014 | 19.5 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| leucylleucine | | peptide | | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| glucuronic acid | | D-glucuronic acid | algal metabolite | 2005 | 2014 | 13.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
| 1-phenazinecarboxylic acid | | aromatic carboxylic acid;
monocarboxylic acid;
phenazines | antifungal agent;
antimicrobial agent;
bacterial metabolite | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| 1-(4-bromophenyl)ethanol | | | | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 |
| cobalt | | cobalt group element atom;
metal allergen | micronutrient | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| p-methoxy-n-methylphenethylamine | | aromatic ether;
secondary amino compound | metabolite | 1963 | 1967 | 59.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| u 69593 | | monocarboxylic acid amide;
N-alkylpyrrolidine;
organic heterobicyclic compound;
oxaspiro compound | anti-inflammatory agent;
diuretic;
kappa-opioid receptor agonist | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| hypotaurine | | aminosulfinic acid;
zwitterion | human metabolite;
metabolite;
mouse metabolite | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| n-chlorotaurine | | | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ci 988 | | | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| deoxyglucose | | | | 1990 | 1997 | 30.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| glyceraldehyde 3-phosphate dehydrogenase (304-313) | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| caprylates | | fatty acid anion 8:0;
straight-chain saturated fatty acid anion | human metabolite;
Saccharomyces cerevisiae metabolite | 2010 | 2016 | 11.0 | low | 1 | 0 | 0 | 1 | 1 | 0 |
| phenazine-1-carboxamide | | aromatic amide;
monocarboxylic acid amide;
phenazines | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ym 022 | | | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone | | dichlorobenzene;
differentiation-inducing factor;
monomethoxybenzene;
resorcinols | eukaryotic metabolite;
signalling molecule | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| lipid x | | N-acyl-D-glucosamine 1-phosphate | Escherichia coli metabolite | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| methotrexate | | dicarboxylic acid;
monocarboxylic acid amide;
pteridines | abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| podophyllic acid | | | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| xylose | | D-xylose | | 1971 | 2011 | 33.7 | low | 0 | 6 | 0 | 4 | 1 | 0 |
| proline | | amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid | algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite | 1975 | 1999 | 37.0 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| glucose 6-(hydrogen sulfate) | | monosaccharide sulfate | | 1963 | 1963 | 61.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 |
| kartocid | | | | 2012 | 2012 | 12.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
| lipid y | | | | 1985 | 1985 | 39.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 |
| i-677 | | L-serine derivative;
non-proteinogenic L-alpha-amino acid | antimetabolite;
antimicrobial agent;
antineoplastic agent;
metabolite | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| metaperiodate | | iodine oxoanion;
monovalent inorganic anion | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| ferrioxamine e | | | | 1995 | 2011 | 21.0 | medium | 0 | 0 | 1 | 0 | 1 | 0 |
| terics | | | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| biotin | | biotins;
vitamin B7 | coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite | 1965 | 2012 | 40.6 | low | 0 | 5 | 1 | 1 | 1 | 0 |
| angiotensin ii | | amino acid zwitterion;
angiotensin II | human metabolite | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| atropine | | | | 1949 | 2000 | 45.9 | low | 1 | 12 | 3 | 0 | 0 | 0 |
| lignin | | | | 1973 | 2022 | 15.3 | low | 0 | 1 | 0 | 2 | 5 | 1 |
| chlorite | | chlorine oxoanion;
monovalent inorganic anion | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| deoxycholic acid | | bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid | human blood serum metabolite | 1975 | 2015 | 32.7 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| cortisone | | 11-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone | human metabolite;
mouse metabolite | 1963 | 1968 | 58.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| glycogen | | | | 1965 | 2006 | 46.6 | low | 0 | 13 | 0 | 1 | 0 | 0 |
| sorbose | | L-sorbose;
sorbopyranose | | 1969 | 2010 | 34.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| arabinose | | L-arabinose | Escherichia coli metabolite;
mouse metabolite | 1973 | 2022 | 25.0 | low | 0 | 2 | 0 | 0 | 2 | 1 |
| fibrin | | peptide | | 1946 | 2014 | 63.9 | low | 0 | 8 | 0 | 0 | 1 | 0 |
| bradykinin | | oligopeptide | human blood serum metabolite;
vasodilator agent | 1950 | 1975 | 60.5 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| glucosamine | | D-glucosamine | Escherichia coli metabolite;
geroprotector;
mouse metabolite | 1970 | 1971 | 53.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| diaminopimelic acid | | 2,6-diaminopimelic acid;
amino acid zwitterion | Escherichia coli metabolite | 2006 | 2014 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| pantetheine | | pantetheines;
thiol | human metabolite;
metabolite;
mouse metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| casein hydrolysate | | | | 2004 | 2009 | 18.0 | low | 0 | 0 | 0 | 4 | 0 | 0 |
| puromycin | | puromycins | antiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor | 1969 | 1974 | 52.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| fructans | | | | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| cellulase | | cellotriose | | 1996 | 2016 | 14.0 | low | 0 | 0 | 1 | 1 | 4 | 0 |
| griseofulvin | | 1-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound | antibacterial agent;
Penicillium metabolite | 1968 | 1968 | 56.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| terconazole | | 1-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ochratoxin a | | isochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative | Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| devazepide | | 1,4-benzodiazepinone;
indolecarboxamide | antineoplastic agent;
apoptosis inducer;
cholecystokinin antagonist;
gastrointestinal drug | 1988 | 2004 | 26.7 | low | 0 | 1 | 10 | 6 | 0 | 0 |
| betadex | | cyclodextrin | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| maleic acid | | butenedioic acid | algal metabolite;
mouse metabolite;
plant metabolite | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| trichostatin a | | antibiotic antifungal agent;
hydroxamic acid;
trichostatin | bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| tretinoin | | retinoic acid;
vitamin A | anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| arachidonic acid | | icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid | Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite | 1991 | 1998 | 29.5 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| retinol | | retinol;
vitamin A | human metabolite;
mouse metabolite;
plant metabolite | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cyanoginosin lr | | microcystin | bacterial metabolite;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
environmental contaminant;
xenobiotic | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| oleic acid | | octadec-9-enoic acid | antioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent | 1986 | 2019 | 24.3 | low | 0 | 1 | 3 | 0 | 2 | 0 |
| tacrolimus | | macrolide lactam | bacterial metabolite;
immunosuppressive agent | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| ferulic acid | | ferulic acids | anti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pectins | | D-galactopyranuronic acid | | 1970 | 2023 | 24.5 | low | 0 | 2 | 1 | 0 | 2 | 1 |
| mycophenolic acid | | 2-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols | anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| lycopene | | acyclic carotene | antioxidant;
plant metabolite | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| dactinomycin | | actinomycin | mutagen | 1965 | 2008 | 39.1 | low | 0 | 4 | 1 | 2 | 0 | 0 |
| riboflavin | | flavin;
vitamin B2 | anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite | 1974 | 2000 | 41.3 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| sodium bicarbonate | | one-carbon compound;
organic sodium salt | antacid;
food anticaking agent | 1984 | 2002 | 31.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| sodium acetate, anhydrous | | organic sodium salt | NMR chemical shift reference compound | 2010 | 2022 | 9.0 | low | 0 | 0 | 0 | 1 | 2 | 1 |
| bromochloroacetic acid | | 2-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound | | 1968 | 2020 | 31.0 | low | 0 | 1 | 1 | 0 | 1 | 0 |
| glycosides | | | | 1963 | 1969 | 58.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| isomethyleugenol | | isomethyleugenol | | 1976 | 2002 | 35.0 | low | 1 | 1 | 0 | 1 | 0 | 0 |
| sesquiterpenes | | | | 1975 | 1975 | 49.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| capsaicin | | capsaicinoid | non-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker | 1992 | 2012 | 25.5 | low | 0 | 0 | 4 | 1 | 1 | 0 |
| tosylarginine methyl ester | | guanidines;
L-arginine ester;
methyl ester;
sulfonamide | | 1959 | 1959 | 65.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| thiourea | | one-carbon compound;
thioureas;
ureas | antioxidant;
chromophore | 1964 | 1974 | 52.8 | low | 1 | 6 | 0 | 0 | 0 | 0 |
| D-fructopyranose | | cyclic hemiketal;
D-fructose;
fructopyranose | sweetening agent | 1952 | 2013 | 37.5 | low | 0 | 9 | 0 | 5 | 2 | 0 |
| nadp | | | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| 1,1-diphenyl-2-picrylhydrazyl | | | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| thiopental | | barbiturates | anticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic | 1966 | 1966 | 58.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ranitidine | | C-nitro compound;
furans;
organic sulfide;
tertiary amino compound | anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic | 1981 | 1996 | 35.3 | low | 7 | 3 | 4 | 0 | 0 | 0 |
| laccase | | | | 2000 | 2022 | 12.4 | low | 0 | 0 | 1 | 1 | 2 | 1 |
| n-bromotaurine | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| alpha-sarcin | | | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nizatidine | | | | 1987 | 1987 | 37.0 | low | 1 | 1 | 0 | 0 | 0 | 0 |
| ranitidine bismuth citrate | | | | 1996 | 1996 | 28.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| 1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester | | | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cystine | | | | 1950 | 2018 | 51.4 | low | 0 | 10 | 0 | 0 | 1 | 0 |
| a 65186 | | | | 2003 | 2004 | 20.8 | high | 0 | 0 | 0 | 4 | 0 | 0 |
| cytellin | | | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ovalbumin | | | | 1964 | 2003 | 43.6 | low | 0 | 3 | 1 | 1 | 0 | 0 |
| sodium dodecyl sulfate | | organic sodium salt | detergent;
protein denaturant | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| chloramine-t | | organic sodium salt | allergen;
antifouling biocide;
disinfectant | 2013 | 2014 | 10.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| alpha-chymotrypsin | | | | 1979 | 2023 | 29.0 | low | 0 | 2 | 0 | 0 | 0 | 1 |
| hydroxyethylcellulose | | | | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| dinoprostone | | prostaglandins E | human metabolite;
mouse metabolite;
oxytocic | 1985 | 1995 | 35.0 | low | 1 | 2 | 1 | 0 | 0 | 0 |
| vitamin k semiquinone radical | | | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| alprostadil | | prostaglandins E | anticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| 5-hydroxy-6,8,11,14-eicosatetraenoic acid | | HETE | human metabolite;
mouse metabolite | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| amphotericin b | | antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic | antiamoebic agent;
antiprotozoal drug;
bacterial metabolite | 1981 | 1981 | 43.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| lutein | | carotenol | food colouring;
plant metabolite | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| esculin | | beta-D-glucoside;
hydroxycoumarin | antioxidant;
metabolite | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| oleylamide | | primary fatty amide | human metabolite;
plant metabolite | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| menaquinone 6 | | | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| naloxone | | morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol | antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist | 1983 | 1983 | 41.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| kallidin | | peptide | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| l 365260 | | benzodiazepine | | 1992 | 1999 | 28.8 | low | 0 | 0 | 4 | 0 | 0 | 0 |
| lysophosphatidic acid | | 1-acyl-sn-glycerol 3-phosphate | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| cytochalasin b | | cytochalasin;
lactam;
lactone;
organic heterotricyclic compound | actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| kn 93 | | monochlorobenzenes;
monomethoxybenzene;
primary alcohol;
sulfonamide;
tertiary amino compound | EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor;
geroprotector | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| lead | | carbon group element atom;
elemental lead;
metal atom | neurotoxin | 1964 | 1991 | 46.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| cesium | | alkali metal atom | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| barium | | alkaline earth metal atom;
elemental barium | | 1964 | 1971 | 56.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| aluminum | | boron group element atom;
elemental aluminium;
metal atom | | 1977 | 1977 | 47.0 | low | 1 | 1 | 0 | 0 | 0 | 0 |
| bismuth | | metal atom;
pnictogen | | 1952 | 1996 | 52.2 | low | 1 | 3 | 1 | 0 | 0 | 0 |
| arsenic | | metalloid atom;
pnictogen | micronutrient | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sulfur | | chalcogen;
nonmetal atom | macronutrient | 1964 | 2007 | 32.8 | low | 0 | 4 | 0 | 5 | 0 | 0 |
| veratrine | | alkaloid | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| cytochalasin e | | cytochalasan alkaloid | metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| fumarates | | butenedioate;
C4-dicarboxylate | human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite | 1971 | 2016 | 41.6 | low | 0 | 4 | 0 | 0 | 1 | 0 |
| cysteine | | cysteinium | fundamental metabolite | 1964 | 2013 | 45.3 | low | 0 | 16 | 3 | 2 | 1 | 0 |
| phosphorus | | monoatomic phosphorus;
nonmetal atom;
pnictogen | macronutrient | 1954 | 2014 | 44.0 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| pepstatin | | pentapeptide;
secondary carboxamide | bacterial metabolite;
EC 3.4.23.* (aspartic endopeptidase) inhibitor | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| triolein | | triglyceride | Caenorhabditis elegans metabolite;
plant metabolite | 1978 | 1978 | 46.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ammonium sulfate | | ammonium salt;
inorganic sulfate salt | fertilizer | 1972 | 2015 | 25.3 | low | 0 | 4 | 1 | 6 | 4 | 0 |
| menaquinone 9 | | menaquinone | Escherichia coli metabolite | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| tetrodotoxin | | azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid | animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| selenium | | chalcogen;
nonmetal atom | micronutrient | 1963 | 1979 | 51.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| tellurium | | chalcogen;
metalloid atom | | 1971 | 1971 | 53.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| polonium | | chalcogen;
metal atom | | 2002 | 2002 | 22.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| oxalates | | | | 1952 | 1967 | 64.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| clinoptilolite | | | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| fce 20700 | | | | 1987 | 1987 | 37.0 | medium | 1 | 1 | 0 | 0 | 0 | 0 |
| bacteriochlorophylls | | | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| nitrofurantoin | | imidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic | antibacterial drug;
antiinfective agent;
hepatotoxic agent | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nocloprost | | | | 1991 | 1991 | 33.0 | low | 1 | 0 | 1 | 0 | 0 | 0 |
| chlorhexidine | | biguanides;
monochlorobenzenes | antibacterial agent;
antiinfective agent | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| nikkomycin | | | | 1992 | 1992 | 32.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| sincalide | | oligopeptide | | 1988 | 2012 | 23.8 | low | 0 | 1 | 2 | 4 | 1 | 0 |
| sincalide | | oligopeptide | | 1988 | 2012 | 24.1 | low | 0 | 1 | 2 | 3 | 1 | 0 |
| pseurotin | | azaspiro compound;
lactam;
oxaspiro compound | metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pentagastrin | | organic molecular entity | | 1974 | 2003 | 39.1 | low | 3 | 16 | 7 | 1 | 0 | 0 |
| mocetinostat | | aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline | antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent | 2004 | 2004 | 20.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| yf 476 | | | | 1998 | 1998 | 26.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| lipid a | | dodecanoate ester;
lipid A;
tetradecanoate ester | Escherichia coli metabolite | 1978 | 1985 | 42.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| ym-254890 | | | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| zeolites | | | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| eledoisin | | peptide | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| angiotensin amide | | oligopeptide | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| macrolactin a | | | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| ribose | | D-ribose;
ribopyranose | | 1970 | 1971 | 53.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| acebutolol | | alpha-D-glucosyl-(1->4)-D-mannopyranose | | 1963 | 2022 | 35.5 | low | 0 | 11 | 1 | 5 | 2 | 1 |
| losartan potassium | | | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | | amino tetrasaccharide;
glucosamine oligosaccharide | epitope | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| bacteriochlorophylls | | bacteriochlorophyll;
methyl ester | | 2006 | 2007 | 17.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
| calcimycin | | benzoxazole | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| acid phosphatase | | | | 1963 | 1982 | 51.5 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| ants | | | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| nad | | organophosphate oxoanion | cofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite | 1972 | 2023 | 39.2 | low | 0 | 3 | 0 | 0 | 0 | 1 |
| melitten | | | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| cholecystokinin | | | | 1965 | 2015 | 31.9 | low | 1 | 12 | 14 | 10 | 2 | 0 |
| ceruletide | | oligopeptide | diagnostic agent;
gastrointestinal drug | 1974 | 1975 | 49.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| gastrins | | | | 1967 | 2010 | 37.8 | low | 18 | 60 | 28 | 4 | 0 | 0 |
| glucagon | | peptide hormone | | 1985 | 1999 | 30.0 | low | 0 | 1 | 2 | 0 | 0 | 0 |
| neuropeptide y | | | | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| pancreastatin | | | | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| tannins | | | | 1969 | 2016 | 25.3 | low | 0 | 1 | 0 | 0 | 2 | 0 |
| glucagon-like peptide 1 | | | | 1998 | 2019 | 14.0 | low | 0 | 0 | 2 | 0 | 4 | 0 |
| gastrin 17 | | gastrin | antineoplastic agent | 1981 | 1995 | 35.2 | low | 0 | 3 | 3 | 0 | 0 | 0 |
| cellulose | | glycoside | | 1968 | 2022 | 17.2 | low | 0 | 2 | 2 | 2 | 8 | 3 |
| ferrous gluconate | | | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| phosphatidylcholines | | 1,2-diacyl-sn-glycero-3-phosphocholine | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| lucifer yellow | | organic lithium salt | fluorochrome | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| bucladesine | | 3',5'-cyclic purine nucleotide | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| sodium hypochlorite | | inorganic sodium salt | bleaching agent;
disinfectant | 1993 | 1993 | 31.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| sodium nitrite | | inorganic sodium salt;
nitrite salt | antidote to cyanide poisoning;
antihypertensive agent;
antimicrobial food preservative;
food antioxidant;
poison | 1983 | 1996 | 34.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| sodium glutamate | | monosodium glutamate | flavouring agent | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| egg white | | | | 1957 | 1973 | 58.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| neurotensin | | peptide hormone | human metabolite;
mitogen;
neurotransmitter;
vulnerary | 1987 | 2015 | 26.7 | low | 0 | 1 | 1 | 0 | 1 | 0 |
| mannans | | | | 2006 | 2011 | 15.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| glycolipids | | | | 1968 | 2014 | 37.8 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| piperidines | | | | 1987 | 1988 | 36.5 | low | 2 | 2 | 0 | 0 | 0 | 0 |
| colistin | | | | 1976 | 1976 | 48.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| methylcellulose | | | | 1964 | 1973 | 54.5 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| vasoactive intestinal peptide | | | | 1983 | 1988 | 38.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| heme | | | | 1970 | 1972 | 53.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| chondroitin | | | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ascorbic acid | | ascorbic acid;
vitamin C | coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent | 1967 | 2020 | 40.5 | low | 0 | 4 | 0 | 1 | 1 | 0 |
| novobiocin | | carbamate ester;
ether;
hexoside;
hydroxycoumarin;
monocarboxylic acid amide;
monosaccharide derivative;
phenols | antibacterial agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Escherichia coli metabolite;
hepatoprotective agent | 1963 | 1983 | 51.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| tetracycline | | | | 1963 | 2011 | 42.3 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| chlortetracycline | | | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| oxytetracycline, anhydrous | | | | 1958 | 1958 | 66.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| gastrin-releasing peptide | | | | 1991 | 1995 | 31.3 | low | 0 | 0 | 3 | 0 | 0 | 0 |
| kaolinite | | aluminosilicate mineral;
mixture | antidiarrhoeal drug;
excipient | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| clay | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| pediocin pa-1 | | | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| agar | | | | 1951 | 2023 | 47.6 | low | 0 | 95 | 6 | 6 | 5 | 2 |
| caseins | | | | 1953 | 2022 | 42.5 | low | 0 | 60 | 13 | 9 | 3 | 2 |
| nattokinase | | | | 2011 | 2014 | 11.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
| hyaluronoglucosaminidase | | | | 1952 | 1974 | 57.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| vitamin b 12 | | | | 1963 | 2019 | 45.7 | low | 0 | 5 | 0 | 0 | 1 | 0 |
| peptide yy | | | | 1999 | 2015 | 17.0 | low | 0 | 0 | 1 | 0 | 1 | 0 |
| lactoferrin | | | | 1974 | 2002 | 37.7 | low | 0 | 2 | 0 | 1 | 0 | 0 |
| orabase | | | | 1979 | 2016 | 27.7 | low | 0 | 1 | 1 | 0 | 1 | 0 |
| thromboplastin | | | | 1966 | 1966 | 58.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| muramidase | | | | 1964 | 2012 | 49.9 | low | 0 | 10 | 0 | 0 | 1 | 0 |
| chondroitin sulfates | | | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| factor a | | | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| levoleucovorin | | 5-formyltetrahydrofolic acid | antineoplastic agent;
metabolite | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| guanine | | 2-aminopurines;
oxopurine;
purine nucleobase | algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite | 1963 | 1973 | 55.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| folic acid | | folic acids;
N-acyl-amino acid | human metabolite;
mouse metabolite;
nutrient | 1957 | 2018 | 43.2 | low | 0 | 3 | 0 | 0 | 1 | 0 |
| rifampin | | cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion | angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor | 1974 | 1980 | 46.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| syringaldazine | | | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| azaguanine | | nucleobase analogue;
triazolopyrimidines | antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor | 1971 | 1974 | 51.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| trypan blue | | | | 1976 | 1976 | 48.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| prodigiosin | | | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| eye | | | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| fructooligosaccharide | | oligosaccharide | | 2004 | 2016 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| concanavalin a | | | | 1979 | 2001 | 39.0 | low | 0 | 5 | 1 | 1 | 0 | 0 |
| phenanthrenes | | | | 2008 | 2023 | 10.2 | low | 0 | 0 | 0 | 1 | 2 | 1 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|
| 2019 Novel Coronavirus Disease | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
| Abdominal Migraine | 0 | | 1952 | 1953 | 71.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Abnormality, Heart | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Abscess | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Ache | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Achlorhydria | 0 | | 1974 | 1992 | 41.0 | low | 1 | 1 | 1 | 0 | 0 | 0 |
| Actinomyces Infections | 0 | | 1969 | 1970 | 54.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Acute Disease | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Acute Liver Injury, Drug-Induced | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Addison's Anemia | 0 | | 1972 | 1992 | 42.0 | low | 1 | 1 | 1 | 0 | 0 | 0 |
| Adenocarcinoma | 0 | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Adenocarcinoma, Basal Cell | 0 | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Adhesions, Tissue | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Aging | 0 | | 1962 | 1993 | 50.0 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| Airway Hyper-Responsiveness | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Allergic Bronchopulmonary Aspergilloses | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Allergic Reaction | 0 | | 1946 | 2005 | 66.6 | low | 0 | 18 | 0 | 1 | 0 | 0 |
| Allergy, Drug | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Allergy, Milk | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Alloxan Diabetes | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 2 | 0 | 0 | 0 |
| Anaphylactic Reaction | 0 | | 1946 | 2005 | 63.1 | low | 0 | 24 | 0 | 1 | 0 | 0 |
| Anaphylaxis | 0 | | 1946 | 2005 | 63.1 | low | 0 | 24 | 0 | 1 | 0 | 0 |
| Anasarca | 0 | | 1965 | 1967 | 58.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Anemia, Hemolytic | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Anemia, Hemolytic, Acquired | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Anesthesia | 0 | | 1966 | 1966 | 58.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Aneuploid | 0 | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Angiogenesis, Pathologic | 0 | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Anorexia | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Anoxemia | 0 | | 1964 | 2005 | 39.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| Anthrax | 0 | | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Arthritides, Bacterial | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Arthus Phenomenon | 0 | | 1968 | 1971 | 54.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Ascites | 0 | | 1970 | 1984 | 47.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Aspergillosis | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Aspergillosis, Allergic Bronchopulmonary | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Aspergillus Infection | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Asthma | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Asthma, Bronchial | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Atopic Hypersensitivity | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Autolysis | 0 | | 1969 | 1976 | 51.0 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Avian Diseases | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Bacillus anthracis Infection | 0 | | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Bacteremia | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Benign Neoplasms | 0 | | 1979 | 2001 | 34.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| Bleeding | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Blood Clot | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Blood Coagulation Disorders | 0 | | 1946 | 1966 | 68.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Blood Poisoning | 0 | | 1974 | 1988 | 42.0 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| Blood Pressure, High | 0 | | 1962 | 1965 | 60.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Blood Pressure, Low | 0 | | 1963 | 1968 | 59.2 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| Body Weight | 0 | | 1950 | 2004 | 48.0 | low | 0 | 2 | 0 | 1 | 0 | 0 |
| Bordetella pertussis Infection, Respiratory | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Bovine Diseases | 0 | | 1969 | 1973 | 53.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Breast Cancer | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Breast Neoplasms | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Brucella Infection | 0 | | 1949 | 1949 | 75.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Brucellosis | 0 | | 1949 | 1949 | 75.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Bunostomiasis | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Burns | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Calcium Metabolism Disorders | 0 | | 2005 | 2005 | 19.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Cancer of Lung | 0 | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Cancer of Mouth | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Cancer of Skin | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Candidiasis, Oral | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Carbon Tetrachloride Poisoning | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Carcinoma 256, Walker | 0 | | 1971 | 1973 | 52.0 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Carcinoma, Ehrlich Tumor | 0 | | 1969 | 1978 | 50.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Cardiovascular Diseases | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Cell Transformation, Neoplastic | 0 | | 1974 | 1979 | 47.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Cells, Neoplasm Circulating | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Central Hypothyroidism | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Cerebral Nocardiosis | 0 | | 1969 | 1970 | 54.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Chemical and Drug Induced Liver Injury | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Cholecystoduodenal Fistula | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Cholera | 0 | | 1969 | 2017 | 44.9 | low | 0 | 6 | 0 | 0 | 1 | 0 |
| Cholera Infantum | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Chronic Disease | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Chronic Illness | 0 | | 2005 | 2005 | 19.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Circulatory Collapse | 0 | | 1946 | 1967 | 69.0 | low | 0 | 40 | 0 | 0 | 0 | 0 |
| Cirrhosis, Liver | 0 | | 1964 | 1987 | 52.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Coagulation Disorders, Blood | 0 | | 1946 | 1966 | 68.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Colitis Gravis | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Colitis, Ulcerative | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Complication, Postoperative | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Complications of Diabetes Mellitus | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Complications, Infectious Pregnancy | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Concomitant Strabismus | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Constriction, Pathologic | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Constriction, Pathological | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Corpus Luteum Cyst | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Corynebacterium diphtheriae Infection | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Cronobacter Infections | 0 | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Curling Ulcer | 0 | | 1964 | 1999 | 42.4 | low | 6 | 15 | 4 | 0 | 0 | 0 |
| Deficiency Disease, Ornithine Carbamoyltransferase | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Delayed Hypersensitivity | 0 | | 1968 | 1978 | 51.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Dental Plaque | 0 | | 1972 | 2001 | 39.2 | low | 0 | 2 | 1 | 1 | 0 | 0 |
| Dermatomycoses | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Dermatophytoses | 0 | | 1969 | 1971 | 54.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Diarrhea | 0 | | 1982 | 1986 | 40.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Diphtheria | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Disease | 0 | | 1947 | 1947 | 77.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Disease Models, Animal | 0 | | 1976 | 2023 | 24.2 | low | 0 | 2 | 1 | 0 | 1 | 1 |
| Diseases of Immune System | 0 | | 1946 | 1955 | 74.4 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| Diseases, Occupational | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Drug Hypersensitivity | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Duodenal Ulcer | 0 | | 1964 | 1999 | 42.4 | low | 6 | 15 | 4 | 0 | 0 | 0 |
| Dysentery | 0 | | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Dysentery, Bacillary | 0 | | 1963 | 1968 | 58.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Dysentery, Shiga bacillus | 0 | | 1963 | 1968 | 58.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| E coli Infections | 0 | | 2009 | 2020 | 9.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Edema | 0 | | 1965 | 1967 | 58.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| EHS Tumor | 0 | | 1980 | 1995 | 37.0 | low | 0 | 2 | 1 | 0 | 0 | 0 |
| Electrolytes | 0 | | 1987 | 1987 | 37.0 | low | 1 | 1 | 0 | 0 | 0 | 0 |
| Emesis | 0 | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Emphysema, Mediastinal | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Encephalitis, Polio | 0 | | 1953 | 1955 | 70.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Endotoxin Shock | 0 | | 1963 | 1968 | 59.1 | low | 0 | 7 | 0 | 0 | 0 | 0 |
| Entamoeba histolytica Infection | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Enterobacteriaceae Infections | 0 | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Eperythrozoonosis | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| ER-Negative PR-Negative HER2-Negative Breast Cancer | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Escherichia coli Infections | 0 | | 2009 | 2020 | 9.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
| Esophageal Reflux | 0 | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Esophagitis, Peptic | 0 | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Esophagitis, Reflux | 0 | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Experimental Leukemia | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Experimental Lung Inflammation | 0 | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Experimental Mammary Neoplasms | 0 | | 1977 | 1977 | 47.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Experimental Neoplasms | 0 | | 1957 | 2015 | 44.4 | low | 0 | 8 | 0 | 0 | 1 | 0 |
| Experimental Radiation Injuries | 0 | | 1953 | 1953 | 71.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Extravascular Hemolysis | 0 | | 1966 | 1976 | 52.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Fasting Hypoglycemia | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Fatigue | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Fever | 0 | | 1963 | 1967 | 59.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Fibrosarcoma | 0 | | 1977 | 1987 | 43.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Fish Diseases | 0 | | 1974 | 1993 | 40.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| Fistula | 0 | | 1974 | 1995 | 39.0 | low | 0 | 2 | 2 | 0 | 0 | 0 |
| Food Poisoning | 0 | | 1971 | 2010 | 33.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| Food Poisoning, Salmonella | 0 | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Foot Rot | 0 | | 1975 | 1975 | 49.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Francisella tularensis Infection | 0 | | 1946 | 1946 | 78.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Fungal Diseases | 0 | | 1982 | 1988 | 40.0 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| Gastric Dilatation | 0 | | 1984 | 1984 | 40.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Gastric Diseases | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Gastric Fistula | 0 | | 1964 | 2000 | 41.4 | low | 0 | 5 | 3 | 0 | 0 | 0 |
| Gastroduodenal Ulcer | 0 | | 1963 | 1973 | 57.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Gastroesophageal Reflux | 0 | | 1988 | 1988 | 36.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Germinoblastoma | 0 | | 1979 | 1981 | 44.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Group A Strep Infection | 0 | | 1957 | 2012 | 44.3 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| Haemophilus Infections | 0 | | 1986 | 1986 | 38.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Heart Defects, Congenital | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Helicobacter Infections | 0 | | 1992 | 2023 | 24.3 | low | 2 | 0 | 5 | 0 | 0 | 1 |
| Hemolysis | 0 | | 1966 | 1976 | 52.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Hemorrhage | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hemorrhagic Diathesis | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hemorrhagic Disorders | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hepatitis | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Herpes Simplex | 0 | | 1970 | 1970 | 54.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Herpes Simplex Virus Infection | 0 | | 1970 | 1970 | 54.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Hives | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hookworm Infections | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Human Trichinellosis | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hyperlipemia | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hyperlipidemias | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hyperparathyroidism | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hyperparathyroidism, Primary | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| Hyperplasia | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hypersensitivity | 0 | | 1946 | 2005 | 66.6 | low | 0 | 18 | 0 | 1 | 0 | 0 |
| Hypertension | 0 | | 1962 | 1965 | 60.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Hypertrophy | 0 | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hypocalcemia | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Hypoglycemia | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hypotension | 0 | | 1963 | 1968 | 59.2 | low | 0 | 6 | 0 | 0 | 0 | 0 |
| Hypothermia | 0 | | 1955 | 1963 | 64.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Hypothermia, Accidental | 0 | | 1955 | 1963 | 64.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Hypothyroidism | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Hypoxia | 0 | | 1964 | 2005 | 39.5 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| Immune System Diseases | 0 | | 1946 | 1955 | 74.4 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| Infant Malnutrition | 0 | | 1955 | 1955 | 69.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infant, Newborn, Diseases | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infection | 0 | | 1959 | 1959 | 65.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infections | 0 | | 1959 | 1959 | 65.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infections, Helicobacter | 0 | | 1992 | 2023 | 24.3 | low | 2 | 0 | 5 | 0 | 0 | 1 |
| Infections, Listeria | 0 | | 1971 | 2012 | 32.5 | low | 0 | 1 | 0 | 0 | 1 | 0 |
| Infections, Nematode | 0 | | 1971 | 1972 | 52.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Infections, Pasteurella | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infections, Salmonella | 0 | | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Infections, Staphylococcal | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Inflammation | 0 | | 1965 | 2005 | 45.5 | low | 0 | 9 | 0 | 1 | 0 | 0 |
| Innate Inflammatory Response | 0 | | 1965 | 2005 | 45.5 | low | 0 | 9 | 0 | 1 | 0 | 0 |
| Keratoacanthoma | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Kidney Calculi | 0 | | 2005 | 2005 | 19.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Kidney Stones | 0 | | 2005 | 2005 | 19.0 | low | 1 | 0 | 0 | 1 | 0 | 0 |
| Lassitude | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Leucocythaemia | 0 | | 1957 | 1968 | 61.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Leukemia | 0 | | 1957 | 1968 | 61.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Leukemia L 1210 | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Leukemia P388 | 0 | | 1994 | 1994 | 30.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Leukocytopenia | 0 | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Leukopenia | 0 | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Liver Cirrhosis | 0 | | 1964 | 1987 | 52.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Liver Diseases | 0 | | 1952 | 1971 | 62.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Liver Dysfunction | 0 | | 1952 | 1971 | 62.5 | low | 0 | 4 | 0 | 0 | 0 | 0 |
| Lung Neoplasms | 0 | | 1987 | 1987 | 37.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Lymphatic Diseases | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Lymphoma | 0 | | 1979 | 1981 | 44.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Manganese Poisoning | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Mast-Cell Sarcoma | 0 | | 1979 | 1987 | 41.7 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Mastitis, Bovine | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Metastase | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Migraine Disorders | 0 | | 1952 | 1953 | 71.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Milk Hypersensitivity | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Moniliasis, Oral | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Morbid Obesity | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Mouth Neoplasms | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Muscle Contraction | 0 | | 1965 | 1971 | 56.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Mycoses | 0 | | 1982 | 1988 | 40.0 | low | 0 | 5 | 0 | 0 | 0 | 0 |
| Nail Fungus | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Necrosis | 0 | | 1973 | 1973 | 51.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Neoplasm Metastasis | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Neoplasms | 0 | | 1979 | 2001 | 34.0 | low | 0 | 1 | 0 | 1 | 0 | 0 |
| Obesity | 0 | | 1999 | 1999 | 25.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Obesity, Morbid | 0 | | 2010 | 2010 | 14.0 | low | 1 | 0 | 0 | 2 | 0 | 0 |
| Onychomycosis | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Ornithine Carbamoyltransferase Deficiency Disease | 0 | | 1997 | 1997 | 27.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Ovarian Cysts | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Pain | 0 | | 1967 | 1967 | 57.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Palmoplantaris Pustulosis | 0 | | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Pancreatic Fistula | 0 | | 1975 | 1992 | 40.5 | low | 0 | 1 | 1 | 0 | 0 | 0 |
| Peptic Ulcer | 0 | | 1963 | 1973 | 57.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Peritoneal Diseases | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Peritonitis | 0 | | 1965 | 2018 | 23.3 | low | 0 | 1 | 1 | 2 | 2 | 0 |
| Pneumatosis Cystoides Intestinalis | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Pneumonia | 0 | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Poliomyelitis | 0 | | 1953 | 1955 | 70.3 | low | 0 | 3 | 0 | 0 | 0 | 0 |
| Postoperative Complications | 0 | | 1995 | 1995 | 29.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Prediabetes | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Prediabetic State | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Pregnancy | 0 | | 1974 | 2012 | 35.0 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| Primary Hyperparathyroidism | 0 | | 2012 | 2012 | 12.0 | low | 1 | 0 | 0 | 0 | 1 | 0 |
| Primary Peritonitis | 0 | | 1965 | 2018 | 23.3 | low | 0 | 1 | 1 | 2 | 2 | 0 |
| Psoriasis | 0 | | 1963 | 1963 | 61.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Pus | 0 | | 1971 | 1974 | 51.5 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Pyloric Stenosis | 0 | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Pyrexia | 0 | | 1963 | 1967 | 59.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Remission, Spontaneous | 0 | | 1980 | 1980 | 44.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Reticulum Cell-Like Sarcoma, Yoshida | 0 | | 1971 | 1971 | 53.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Salmonella Food Poisoning | 0 | | 1991 | 1991 | 33.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Salmonella Infections, Animal | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Sarcoma 180 | 0 | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Schwartzman Phenomenon | 0 | | 1969 | 1969 | 55.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Sensitivity and Specificity | 0 | | 2002 | 2017 | 14.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
| Sepsis | 0 | | 1974 | 1988 | 42.0 | low | 0 | 8 | 0 | 0 | 0 | 0 |
| Shock | 0 | | 1946 | 1967 | 69.0 | low | 0 | 40 | 0 | 0 | 0 | 0 |
| Shock, Septic | 0 | | 1963 | 1968 | 59.1 | low | 0 | 7 | 0 | 0 | 0 | 0 |
| Skin Neoplasms | 0 | | 1972 | 1972 | 52.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Staphylococcal Infections | 0 | | 1964 | 1964 | 60.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Starvation | 0 | | 1972 | 1972 | 52.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Strabismus | 0 | | 1962 | 1962 | 62.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Streptococcal Infections | 0 | | 1957 | 2012 | 44.3 | low | 0 | 2 | 0 | 0 | 1 | 0 |
| Swine Diseases | 0 | | 1986 | 1986 | 38.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Thrombocytopenia | 0 | | 1946 | 1946 | 78.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Thrombopenia | 0 | | 1946 | 1946 | 78.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Thrombosis | 0 | | 1968 | 1968 | 56.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Tinea | 0 | | 1969 | 1971 | 54.0 | low | 0 | 2 | 0 | 0 | 0 | 0 |
| Trichinellosis | 0 | | 2003 | 2003 | 21.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
| Trichostrongylosis | 0 | | 1985 | 1985 | 39.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Triple Negative Breast Neoplasms | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Trypanosomiasis | 0 | | 1970 | 1970 | 54.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Tularemia | 0 | | 1946 | 1946 | 78.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Urticaria | 0 | | 1974 | 1974 | 50.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Vascular Diseases | 0 | | 1947 | 1947 | 77.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Vibrio cholerae Infection | 0 | | 1969 | 2017 | 44.9 | low | 0 | 6 | 0 | 0 | 1 | 0 |
| Visceral Pain | 0 | | 2012 | 2012 | 12.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
| Vomiting | 0 | | 1965 | 1965 | 59.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
| Whooping Cough | 0 | | 1957 | 1957 | 67.0 | low | 0 | 1 | 0 | 0 | 0 | 0 |
Effects of aging on gastrin and somatostatin secretion from isolated perfused rat stomach.Digestive diseases and sciences, , Volume: 38, Issue:2, 1993
Studies on the endogenous metabolism and senescence of starved Sarcina lutea.The Biochemical journal, , Volume: 102, Issue:1, 1967
Aging and sensory thresholds.Journal of gerontology, , Volume: 17, 1962
Biotherapies of chronic diseases in the inter-war period: from Witte's peptone to Penicillium extract.Studies in history and philosophy of biological and biomedical sciences, , Volume: 36, Issue:4, 2005
Insulin-induced enhancement of anaphylactoid reaction to a non-carbohydrate antigen.Experientia, , Feb-15, Volume: 25, Issue:2, 1969
[The role of the nervous system in the development and outcome of peptone and allergic shock].Vrachebnoe delo, , Volume: 4, 1968
Histamine release in guinea pig anaphylaxis. II. Inhibiting effect of specific versus nonspecific (peptone) desensitization.Annals of allergy, , Volume: 25, Issue:6, 1967
[On modes of stimulation of the rat adrenal medulla].Archives internationales de pharmacodynamie et de therapie, , Volume: 160, Issue:1, 1966
Comparison of the effects of various agents on histamine release and mast cells in the rat, in vivo and in vitro.International archives of allergy and applied immunology, , Volume: 28, Issue:5, 1965
Peptonic and anaphylactic shock in the rat.Acta physiologica latino americana, , Volume: 15, Issue:4, 1965
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. I. THE ROLE OF HISTAMINE IN ANAPHYLACTIC SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. III. EFFECT OF COMPOUND 48/80 ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
PLASMA PHOSPHATASE, CHOLINESTERASE AND PEPTONASE IN ANAPHYLACTIC SHOCK.Acta microbiologica Academiae Scientiarum Hungaricae, , Volume: 10, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. II. THE ROLE OF HISTAMINE IN PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
[Role of the liver in peptone anaphylactic shock in dog].Acta gastro-enterologica Belgica, , Volume: 16, Issue:3, 1953
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
[Effect of splanchnic nerve stimulation on the course of experimental shock].Acta physiologica Polonica, , Volume: 16, Issue:5
Avian peritoneal exudate cells: a comparison of stimulation protocols.Developmental and comparative immunology, ,Spring, Volume: 8, Issue:2, 1984
Immunogenicity of lysosomal fractions prepared from leucocytes which pinocytized endotoxin.Zeitschrift fur Immunitatsforschung, Allergie und klinische Immunologie, , Volume: 139, Issue:3, 1970
Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks.BMC infectious diseases, , 11-21, Volume: 17, Issue:1, 2017
A coagglutination test to detect vibrio cholerae in feces alkaline peptone water cultures.The Southeast Asian journal of tropical medicine and public health, , Volume: 13, Issue:3, 1982
[Experimentally induced cholera in guinea pigs. I. Elaboration of the method of infection].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Issue:11, 1976
Holding media for the transport of Vibrio cholerae from field to laboratory.The American journal of tropical medicine and hygiene, , Volume: 20, Issue:5, 1971
In vitro and in vivo studies of streptomycin-dependent cholera vibrios.Applied microbiology, , Volume: 19, Issue:3, 1970
[Microbiological diagnosis of cholera].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 211, Issue:1, 1969
[The bacteriological diagnosis of Vibrio El Tor infection].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 212, Issue:1, 1969
[Laboratory diagnostics of acute enteric infections under the conditions of the work of the specialized epidemic brigade during liquidation of the consequences of the emergency situations].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Issue:6 Suppl
Effects of S-0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats.Alimentary pharmacology & therapeutics, , Volume: 13, Issue:1, 1999
Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.Digestive diseases and sciences, , Volume: 38, Issue:9, 1993
Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects.Gastroenterology, , Volume: 102, Issue:4 Pt 1, 1992
Effects of nocloprost on gastric functions in man.Scandinavian journal of gastroenterology, , Volume: 26, Issue:11, 1991
Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients.Agents and actions, , Volume: 25, Issue:1-2, 1988
Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.International journal of clinical pharmacology, therapy, and toxicology, , Volume: 24, Issue:12, 1986
Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.Digestion, , Volume: 32, Issue:4, 1985
Glucose perfusion intragastric titration.Digestive diseases and sciences, , Volume: 29, Issue:4, 1984
[Acid secretion and gastrin release following stimulation with intragastric instillation of a peptone solution in healthy probands and patients with duodenal ulcer].Zeitschrift fur Gastroenterologie, , Volume: 20, Issue:10, 1982
Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.The Journal of clinical investigation, , Volume: 65, Issue:2, 1980
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.Scandinavian journal of gastroenterology. Supplement, , Volume: 66, 1980
Intragastric titration of peptone-stimulated gastric acid secretion.Acta medica Academiae Scientiarum Hungaricae, , Volume: 35, Issue:2, 1978
Perfusion of the proximal small intestine with peptone stimulates gastric acid secretion in man.Gastroenterology, , Volume: 73, Issue:4 Pt 1, 1977
Effect of synthetic 15-methyl analog of PGE2 on gastric acid and serum gastrin response to peptone meal, pentagastrin, and histamine in duodenal ulcer patients.The American journal of digestive diseases, , Volume: 21, Issue:4, 1976
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man.The American journal of digestive diseases, , Volume: 19, Issue:7, 1974
Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.The New England journal of medicine, , Aug-22, Volume: 291, Issue:8, 1974
Effect of atropine on gastrin and gastric acid response to peptone meal.The Journal of clinical investigation, , Volume: 54, Issue:3, 1974
Serum gastrin and gastric acid responses to meals at various pH levels in man.Gut, , Volume: 15, Issue:7, 1974
REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.Gut, , Volume: 5, 1964
Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH.Reviews of infectious diseases, , Volume: 13 Suppl 8
Evaluation of the impact of buffered peptone water composition on the discrimination between Salmonella enterica and Escherichia coli by Raman spectroscopy.Analytical and bioanalytical chemistry, , Volume: 412, Issue:15, 2020
Pet secretion, internalization and induction of cell death during infection of epithelial cells by enteroaggregative Escherichia coli.Microbiology (Reading, England), , Volume: 155, Issue:Pt 9, 2009
Anti-inflammatory evaluation of cryogenine.Journal of pharmaceutical sciences, , Volume: 56, Issue:11, 1967
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
Gonorrhoea as treated by pyrexia induced by peptone, a protein split product.Indian journal of venereal diseases and dermatology, , Volume: 13, Issue:4
Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.Acta microbiologica Hungarica, , Volume: 34, Issue:3-4, 1987
Effect of concanavalin A on the cytotoxicity of rat peritoneal macrophages.Journal of the Reticuloendothelial Society, , Volume: 25, Issue:1, 1979
Anti-inflammatory consequences of transplanted tumors.Advances in experimental medicine and biology, , Volume: 121B, 1979
Macrophage processing of antigen for induction of tumor immunity.Cancer research, , Volume: 37, Issue:6, 1977
Some factors influencing the haemolysis of Bordetella bronchiseptica.Acta pathologica et microbiologica Scandinavica. Section B, Microbiology, , Volume: 84, Issue:2, 1976
[Some properties of carrier strains of Listeria monocytogenes (author's transl)].Medical microbiology and immunology, , Sep-19, Volume: 161, Issue:4, 1975
[The bacteriological diagnosis of Vibrio El Tor infection].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 212, Issue:1, 1969
[Observations on focal hemodestruction (Mueller's phenomenon) in staphylococci of various origin].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Volume: 43, Issue:3, 1966
Biotherapies of chronic diseases in the inter-war period: from Witte's peptone to Penicillium extract.Studies in history and philosophy of biological and biomedical sciences, , Volume: 36, Issue:4, 2005
[Immunization in allergic patients. 1].Medizinische Klinik, , Volume: 68, Issue:27, 1973
[Pathergy to humidity. Hydrogeological study of the Brussels region].Acta oto-rhino-laryngologica Belgica, , Volume: 26, Issue:4, 1972
[Side reactions of tetanus toxoid. I. Sensitizing ability of materials included in the medium].Nihon saikingaku zasshi. Japanese journal of bacteriology, , Volume: 24, Issue:8, 1969
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
[Role of the liver in peptone anaphylactic shock in dog].Acta gastro-enterologica Belgica, , Volume: 16, Issue:3, 1953
The effects of anaphylactic and peptone shock on the coagulability of rabbit and guinea-pig blood.The Journal of pharmacy and pharmacology, , Volume: 5, Issue:9, 1953
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
Formation of bradykinin in anaphylactic and peptone shock.The American journal of physiology, , Volume: 163, Issue:2, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides.The Journal of experimental medicine, , Volume: 90, Issue:1, 1949
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
[On cardiovascular effects of peptone in the rat].Archives internationales de physiologie et de biochimie, , Volume: 73, Issue:1, 1965
[ON ARTERIAL HYPERTENSION INDUCED BY PEPTONE IN RATS].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 158, 1964
[Comparative study of hypertensin, adrenalin and noradrenalin peptone shock].Archivos del Instituto de Farmacologia Experimental (Medicina), , Volume: 14, 1962
The effect of peptone shock on oliguric-hypertensive bladder reflex.Acta physiologica Polonica, , Volume: 26, Issue:1
A study of the bronchoconstrictor and hypotensive actions of curarizing drugs by Charles M. Landmesser.International anesthesiology clinics, ,Summer, Volume: 6, Issue:2, 1968
[On modes of stimulation of the rat adrenal medulla].Archives internationales de pharmacodynamie et de therapie, , Volume: 160, Issue:1, 1966
[On cardiovascular effects of peptone in the rat].Archives internationales de physiologie et de biochimie, , Volume: 73, Issue:1, 1965
[ROLE OF PLASMIN IN PEPTONE-INDUCED ARTERIAL HYPOTENSION IN RATS].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 158, 1964
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[Peptone shock in artificial hypothermia in dogs].Acta physiologica Polonica, , Volume: 8, Issue:4, 1957
[Modification of blood pressure in peptone shock in hypothermia in animals].Glasnik (Srpska akademija nauka), , Issue:9, 1955
[The course of peptone shock in artificial hypothermia in dogs].Archives internationales de pharmacodynamie et de therapie, , Volume: 117, Issue:3-4
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum.Journal of leukocyte biology, , Volume: 77, Issue:3, 2005
Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model.Arthritis and rheumatism, , Volume: 32, Issue:5, 1989
A macrophage chemotaxis inhibitors produced by neoplasms: characterization of its biological activity.Advances in experimental medicine and biology, , Volume: 121B, 1979
Anti-inflammatory consequences of transplanted tumors.Advances in experimental medicine and biology, , Volume: 121B, 1979
The inflammatory response and resistance to endotoxin in mice.Journal of immunology (Baltimore, Md. : 1950), , Volume: 120, Issue:1, 1978
Cell-specific defect in monocyte function during tumor growth.Journal of the National Cancer Institute, , Volume: 57, Issue:1, 1976
Ultrastructure of synovial membrane in pyogenic arthritis.Archives of pathology, , Volume: 96, Issue:3, 1973
Intraocular penetration of carbenicillin in the rabbit.American journal of ophthalmology, , Volume: 75, Issue:2, 1973
Chemotaxis of leucocytes.Experientia, , Jul-15, Volume: 24, Issue:7, 1968
THE RELATION OF INFLAMMATION TO THE MOLECULAR STRUCTURE OF CARBON COMPOUNDS SOLUBLE IN THE FLUIDS OF THE BODY.The Journal of experimental medicine, , Apr-01, Volume: 121, 1965
Mononuclear phagocytic cells in peritoneal exudates of guinea pigs: a comparison of inducing agents.Allergologia et immunopathologia, , Volume: 13, Issue:6
Fibrinolytic activity of human "peptone-precipitated" plasma euglobulins.Thrombosis et diathesis haemorrhagica, , Jul-31, Volume: 19, Issue:3, 1968
Effect of citrovorum factor and peptones on mouse leukemia cells L-5178 in tissue culture.Science (New York, N.Y.), , Nov-15, Volume: 126, Issue:3281, 1957
Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.The Journal of clinical investigation, , Volume: 79, Issue:4, 1987
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.Gut, , Volume: 5, 1964
Examinations on hepato-thyroidal correlations in liver lesion.Endokrinologie, , Volume: 57, Issue:3, 1971
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
[The alkalimetric determination of the peptone-splitting effect of the blood serum in liver diseases and other diseases].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, , May-01, Volume: 14, Issue:9, 1959
[Splitting of peptones by blood serum in various diseases especially in liver diseases].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, , Jun-15, Volume: 7, Issue:12, 1952
Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.Journal of immunology (Baltimore, Md. : 1950), , Volume: 127, Issue:1, 1981
Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.International journal of cancer, , Jun-15, Volume: 23, Issue:6, 1979
[Effect of insulin on growth, glucose uptake and lactate production of beating rat heart cells in primary culture].Acta biologica et medica Germanica, , Volume: 26, Issue:2, 1971
The inhibition of induced motor activity in transplanted fundic pouches.The Journal of physiology, , Volume: 188, Issue:1, 1967
[On the influence of peptone on the inhibition of a kinin-producing system through proteinase inhibitors. Studies on the problematic nature of the mechanism of peptone shock].Wiener medizinische Wochenschrift (1946), , Jul-03, Volume: 115, Issue:27, 1965
Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 7, Issue:3, 1988
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia.Journal of clinical microbiology, , Volume: 21, Issue:4, 1985
Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 17, Issue:6, 1983
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Production of ascospores by Piedraia hortai in vitro.Mycologia, , Volume: 63, Issue:3
The effects of peptide-precipitating lignosulphonic acids on the proteolytic activity of pepsin in vitro and on the response of pigs to an ulcer inducing diet.Acta veterinaria Scandinavica, , Volume: 14, Issue:1, 1973
EFFECTS OF FREEZING ON THE GASTRIC MUCOSA OF DOGS.Gastroenterology, , Volume: 46, 1964
THE EFFECT OF CORTICOTROPIN ON THE ANTRAL PHASE OF GASTRIC SECRETION.JAMA, , Dec-14, Volume: 186, 1963
Structure and Anti-Inflammatory Activity of a New Unusual Fucosylated Chondroitin Sulfate from Marine drugs, , Oct-17, Volume: 16, Issue:10, 2018
No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse.International journal of hematology, , Volume: 100, Issue:2, 2014
Monomeric and multimeric blockers of selectins: comparison of in vitro and in vivo activity.Biochemistry. Biokhimiia, , Volume: 70, Issue:4, 2005
The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum.Journal of leukocyte biology, , Volume: 77, Issue:3, 2005
Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand.Biochemistry and molecular biology international, , Volume: 43, Issue:2, 1997
[The influence of subphlogogenous thermal factors on the development of noninfectious inflammation in the peritoneum].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 60, Issue:10, 1965
[Experimental poliomyelitis and attempted treatment].Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, , Volume: 11, Issue:3, 1955
[Treatment of acute poliomyelitis].Annales medico-psychologiques, , Volume: 111, Issue:2 3, 1953
[Acute poliomyelitis and peptone shock].Revue medicale de la Suisse romande, , Volume: 73, Issue:7, 1953
Survival and biofilm formation by Group B streptococci in simulated vaginal fluid at different pHs.Antonie van Leeuwenhoek, , Volume: 101, Issue:3, 2012
[Bacteriological peptone obtained from residues of human placenta (author's transl)].Annales pharmaceutiques francaises, , Volume: 39, Issue:1, 1981
The quantitative partition of the albumin fraction of milk serum proteins by gel chromatography.The Journal of dairy research, , Volume: 41, Issue:2, 1974
[Interference of peptone used for desensitization, with the value of ovarian hormones].Monitore ostetrico-ginecologico, , Volume: 22, Issue:4
Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks.BMC infectious diseases, , 11-21, Volume: 17, Issue:1, 2017
Comparison of rose bengal-chloramphenicol and modified aureomycin-rose bengal-glucose-peptone agar as media for the enumeration of molds and yeasts in water by membrane filtration techniques.Journal of microbiological methods, , Volume: 76, Issue:3, 2009
Simple procedure for rapid identification of Vibrio cholerae from the aquatic environment.Applied and environmental microbiology, , Volume: 68, Issue:2, 2002
Properties of the immunogenic and sensitizing activities of Bordetella pertussis in mice. I. Enhancement of peptone shock.The Journal of allergy, , Volume: 39, Issue:1, 1967
[On biocontrolled dosages in the therapy of experimental cardiovascular insufficiency].Kardiologiia, , Volume: 7, Issue:5, 1967
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. III. EFFECT OF COMPOUND 48/80 ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. I. THE ROLE OF HISTAMINE IN ANAPHYLACTIC SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. II. THE ROLE OF HISTAMINE IN PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[Comparative study of hypertensin, adrenalin and noradrenalin peptone shock].Archivos del Instituto de Farmacologia Experimental (Medicina), , Volume: 14, 1962
[Peptone shock in artificial hypothermia in dogs].Acta physiologica Polonica, , Volume: 8, Issue:4, 1957
[Peptone shock in artificial hibernation in dogs].Acta physiologica Polonica, , Volume: 8, Issue:3-3a, 1957
Production of peptone shock in mice following administration of H. pertussis vaccine.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 95, Issue:1, 1957
[Disorders of vascular permeability in shock; electrophoretic investigation of protein content of lymph in the development of peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 44, Issue:11, 1957
[Thrombin time and antithrombinic power of plasma during peptonic shock].Le Sang, , Volume: 27, Issue:9, 1956
[Modification of blood pressure in peptone shock in hypothermia in animals].Glasnik (Srpska akademija nauka), , Issue:9, 1955
[Experimental poliomyelitis and attempted treatment].Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, , Volume: 11, Issue:3, 1955
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
Activation of proteolytic enzymes in peptone shock in frogs.Archives internationales de pharmacodynamie et de therapie, , Oct-15, Volume: 103, Issue:4, 1955
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
[Capillary permeability in peptone shock; rate of disappearance of radioiodine-labeled protein from the blood in peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 38, Issue:11, 1954
The effects of anaphylactic and peptone shock on the coagulability of rabbit and guinea-pig blood.The Journal of pharmacy and pharmacology, , Volume: 5, Issue:9, 1953
[Acute poliomyelitis and peptone shock].Revue medicale de la Suisse romande, , Volume: 73, Issue:7, 1953
[Hepatic mastocytes in dog during peptone-induced shock].Acta haematologica, , Volume: 10, Issue:3, 1953
[Absence of modifications of hepatic mastocytes during peptone shock].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 147, Issue:9-10, 1953
[Effect of R.P. 4560 on peptone shock in the dog and the pig].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 147, Issue:19-20, 1953
New antiheparin agent: polybrene; effect in peptone shock and in experimental radiation injury.A.M.A. archives of surgery, , Volume: 66, Issue:4, 1953
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
Formation of bradykinin in anaphylactic and peptone shock.The American journal of physiology, , Volume: 163, Issue:2, 1950
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Fibrinolysis in peptone shock.Federation proceedings, , Volume: 6, Issue:1 Pt 2, 1947
Release of proteolytic enzyme in anaphylactic and peptone shock in vitro.Lancet (London, England), , May-24, Volume: 1, Issue:6456, 1947
Activation of serum protease in peptone shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 66, Issue:2, 1947
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
Coagulation defect in the shocks produced by trypsin, peptone and ascaris extracts.Experimental medicine and surgery, , Volume: 4, 1946
Heredity of Rh blood types; improved nomenclature; additional family studies with special reference to Hr.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 61, 1946
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
[Effect of splanchnic nerve stimulation on the course of experimental shock].Acta physiologica Polonica, , Volume: 16, Issue:5
The effect of peptone shock on oliguric-hypertensive bladder reflex.Acta physiologica Polonica, , Volume: 26, Issue:1
[Electroencephalographic characteristics of peptone shock and its prevention with hydrocortisone].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Volume: 14, Issue:3
Influence of Ultracorten H on blood supply of the kidneys in peptone shock and in experimental injury of the heart with silver nitrate in rabbits.Materia medica Polona. Polish journal of medicine and pharmacy, , Volume: 7, Issue:4
[On the problem of the course of peptone shock in radiation sickness].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Volume: 5
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
[The course of peptone shock in artificial hypothermia in dogs].Archives internationales de pharmacodynamie et de therapie, , Volume: 117, Issue:3-4
[COMPARATIVE STUDIES ON THE BLOOD TRANSAMINASE ACTIVITY IN EXPERIMENTAL SHOCK. IV. GLUCAMIC-OXALOACETIC AND GLUTAMIC-PYRUVIC TRANSAMINASE ACTIVITY IN THE BLOOD SERUM IN INSULIN AND PEPTONE SHOCK].Acta physiologica Polonica, , Volume: 15
The influence of stimulation of the splanchnic nerves on the course of peptone shock in dogs deprived of the adrenal medullary substance.Acta medica Polona, , Volume: 9, Issue:1, 1968
[The course of experimental peptone shock with preliminary administration of desoxycorticosterone acetate (DOCA)].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 63, Issue:2, 1967
[Permeability of the hemato-encephalitic barrier (HEB) for P32 in peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 60, Issue:11, 1965
Peptonic and anaphylactic shock in the rat.Acta physiologica latino americana, , Volume: 15, Issue:4, 1965
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
Survival and biofilm formation by Group B streptococci in simulated vaginal fluid at different pHs.Antonie van Leeuwenhoek, , Volume: 101, Issue:3, 2012
[The antimicrobial action of potential thiol reagents].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 14, Issue:4, 1970
Enhancement of mousevirulence of group A streptococci.Nature, , Nov-23, Volume: 180, Issue:4595, 1957
The effects of sodium sulfite on Helicobacter pylori by establishing a hypoxic environment.Toxicology and applied pharmacology, , 07-01, Volume: 470, 2023
Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.Alimentary pharmacology & therapeutics, , Volume: 14, Issue:6, 2000
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.Alimentary pharmacology & therapeutics, , Volume: 10, Issue:6, 1996
Evaluation of three commercially available blood culture systems for cultivation of Helicobacter pylori.Journal of clinical microbiology, , Volume: 32, Issue:6, 1994
Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.Digestive diseases and sciences, , Volume: 38, Issue:9, 1993
Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects.Gastroenterology, , Volume: 102, Issue:4 Pt 1, 1992
Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH.Reviews of infectious diseases, , Volume: 13 Suppl 8
Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 7, Issue:3, 1988
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia.Journal of clinical microbiology, , Volume: 21, Issue:4, 1985
Clinical comparison of an agar slide blood culture bottle with tryptic soy broth and a conventional blood culture bottle with supplemented peptone broth.Journal of clinical microbiology, , Volume: 21, Issue:5, 1985
Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 17, Issue:6, 1983
Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Comparative evaluation of three different commercial blood culture media for recovery of anaerobic organisms.Journal of clinical microbiology, , Volume: 5, Issue:5, 1977
Detection of bacteremia with liquid media containing sodium polyanetholsulfonate.Applied microbiology, , Volume: 27, Issue:1, 1974
Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 7, Issue:3, 1988
Clinical comparison of an agar slide blood culture bottle with tryptic soy broth and a conventional blood culture bottle with supplemented peptone broth.Journal of clinical microbiology, , Volume: 21, Issue:5, 1985
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia.Journal of clinical microbiology, , Volume: 21, Issue:4, 1985
Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 17, Issue:6, 1983
Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Comparative evaluation of three different commercial blood culture media for recovery of anaerobic organisms.Journal of clinical microbiology, , Volume: 5, Issue:5, 1977
Detection of bacteremia with liquid media containing sodium polyanetholsulfonate.Applied microbiology, , Volume: 27, Issue:1, 1974
[The resistance of the causative organisms of actinomycosis and nocardiosis to some environmental factors. II. The survival in distilled water and in simple aqueous solutions].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 215, Issue:2, 1970
[The resistance of the causative organisms of actinomycosis and nocardiosis to some environmental factors. I. The resistance to ultraviolet rays].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 211, Issue:4, 1969
Biotherapies of chronic diseases in the inter-war period: from Witte's peptone to Penicillium extract.Studies in history and philosophy of biological and biomedical sciences, , Volume: 36, Issue:4, 2005
Insulin-induced enhancement of anaphylactoid reaction to a non-carbohydrate antigen.Experientia, , Feb-15, Volume: 25, Issue:2, 1969
[The role of the nervous system in the development and outcome of peptone and allergic shock].Vrachebnoe delo, , Volume: 4, 1968
Histamine release in guinea pig anaphylaxis. II. Inhibiting effect of specific versus nonspecific (peptone) desensitization.Annals of allergy, , Volume: 25, Issue:6, 1967
[On modes of stimulation of the rat adrenal medulla].Archives internationales de pharmacodynamie et de therapie, , Volume: 160, Issue:1, 1966
Comparison of the effects of various agents on histamine release and mast cells in the rat, in vivo and in vitro.International archives of allergy and applied immunology, , Volume: 28, Issue:5, 1965
Peptonic and anaphylactic shock in the rat.Acta physiologica latino americana, , Volume: 15, Issue:4, 1965
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. I. THE ROLE OF HISTAMINE IN ANAPHYLACTIC SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. II. THE ROLE OF HISTAMINE IN PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. III. EFFECT OF COMPOUND 48/80 ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
PLASMA PHOSPHATASE, CHOLINESTERASE AND PEPTONASE IN ANAPHYLACTIC SHOCK.Acta microbiologica Academiae Scientiarum Hungaricae, , Volume: 10, 1963
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
[Role of the liver in peptone anaphylactic shock in dog].Acta gastro-enterologica Belgica, , Volume: 16, Issue:3, 1953
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
[Effect of splanchnic nerve stimulation on the course of experimental shock].Acta physiologica Polonica, , Volume: 16, Issue:5
The influence of hypothermia on Arthus-phenomenon and leucotaxis.Experientia, , Dec-15, Volume: 27, Issue:12, 1971
Chemotaxis of leucocytes.Experientia, , Jul-15, Volume: 24, Issue:7, 1968
Preparation and evaluation of two microbiological media from shrimp heads and hulls.Applied and environmental microbiology, , Volume: 31, Issue:1, 1976
Formation and release of hyaluronidase and aminopeptidase in non-growing cells of Streptococcus mitis, ATCC 903.Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology, , Volume: 82B, Issue:5, 1974
Physiological studies on Clostridium botulinum, type F. Progress report, December 1, 1965-November 30, 1966. ORO-3347-3.ORO [reports]. U.S. Atomic Energy Commission, , 1969
The ontogeny of the postingestive inhibitory effect of peptone in rats.Physiology & behavior, , Volume: 82, Issue:1, 2004
[Metabolism of arsenic. (12). Effects of polypeptone and polytamine on arsenic excretion and accumulation in certain organs].Nihon yakurigaku zasshi. Folia pharmacologica Japonica, , Volume: 70, Issue:6, 1974
[Effect of a pancreatic peptone on the growth and weight of protein-deficient rats].Zeitschrift fur die gesamte experimentelle Medizin, , Volume: 115, Issue:5, 1950
Evidence for compromise of tumour immunity in rats by a non-specific blocking serum factor that inactivates macrophages.British journal of experimental pathology, , Volume: 54, Issue:3, 1973
[Relations between tumor growth and immunity].Schweizerische medizinische Wochenschrift, , Aug-19, Volume: 102, Issue:33, 1972
Tumour growth and non-specific immunity in rats: the mechanisms involved in inhibition of tumour growth.British journal of experimental pathology, , Volume: 53, Issue:5, 1972
Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats.Lancet (London, England), , Oct-16, Volume: 2, Issue:7729, 1971
Antibody-dependent lysis of tumor cells in vivo. II. Elimination of chromium-51 as a measurement of cytolysis.Journal of the National Cancer Institute, , Volume: 61, Issue:4, 1978
Evidence for compromise of tumour immunity in rats by a non-specific blocking serum factor that inactivates macrophages.British journal of experimental pathology, , Volume: 54, Issue:3, 1973
Effect of phytohaemagglutinin on Ehrlich ascites carcinoma.British journal of cancer, , Volume: 23, Issue:3, 1969
Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks.BMC infectious diseases, , 11-21, Volume: 17, Issue:1, 2017
A coagglutination test to detect vibrio cholerae in feces alkaline peptone water cultures.The Southeast Asian journal of tropical medicine and public health, , Volume: 13, Issue:3, 1982
[Experimentally induced cholera in guinea pigs. I. Elaboration of the method of infection].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Issue:11, 1976
Holding media for the transport of Vibrio cholerae from field to laboratory.The American journal of tropical medicine and hygiene, , Volume: 20, Issue:5, 1971
In vitro and in vivo studies of streptomycin-dependent cholera vibrios.Applied microbiology, , Volume: 19, Issue:3, 1970
[The bacteriological diagnosis of Vibrio El Tor infection].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 212, Issue:1, 1969
[Microbiological diagnosis of cholera].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 211, Issue:1, 1969
[Laboratory diagnostics of acute enteric infections under the conditions of the work of the specialized epidemic brigade during liquidation of the consequences of the emergency situations].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Issue:6 Suppl
A comparison of human dental plaque microcosm biofilms grown in an undefined medium and a chemically defined artificial saliva.Archives of oral biology, , Volume: 46, Issue:6, 2001
pH responses to sucrose and the formation of pH gradients in thick 'artificial mouth' microcosm plaques.Archives of oral biology, , Volume: 37, Issue:11, 1992
[Leptotrichia buccalis--culture, biochemistry and antibiotics].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie, , Volume: 228, Issue:1, 1974
Some factors affecting the metabolism of fructan by human oral flora.Archives of oral biology, , Volume: 17, Issue:1, 1972
The effects of sodium sulfite on Helicobacter pylori by establishing a hypoxic environment.Toxicology and applied pharmacology, , 07-01, Volume: 470, 2023
Structure and Anti-Inflammatory Activity of a New Unusual Fucosylated Chondroitin Sulfate from Marine drugs, , Oct-17, Volume: 16, Issue:10, 2018
Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog.Gastroenterology, , Volume: 105, Issue:4, 1993
Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model.Arthritis and rheumatism, , Volume: 32, Issue:5, 1989
[Experimentally induced cholera in guinea pigs. I. Elaboration of the method of infection].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Issue:11, 1976
[Effect of peptone blocking asbestos-induced carcinogenesis in rats].Gigiena i sanitariia, , Issue:1
The effect of peptone shock on oliguric-hypertensive bladder reflex.Acta physiologica Polonica, , Volume: 26, Issue:1
Effects of S-0509, a novel CCKB/gastrin receptor antagonist, on acid secretion and experimental duodenal ulcers in rats.Alimentary pharmacology & therapeutics, , Volume: 13, Issue:1, 1999
Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.Digestive diseases and sciences, , Volume: 38, Issue:9, 1993
Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects.Gastroenterology, , Volume: 102, Issue:4 Pt 1, 1992
Effects of nocloprost on gastric functions in man.Scandinavian journal of gastroenterology, , Volume: 26, Issue:11, 1991
Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients.Agents and actions, , Volume: 25, Issue:1-2, 1988
Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.International journal of clinical pharmacology, therapy, and toxicology, , Volume: 24, Issue:12, 1986
Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.Digestion, , Volume: 32, Issue:4, 1985
Glucose perfusion intragastric titration.Digestive diseases and sciences, , Volume: 29, Issue:4, 1984
[Acid secretion and gastrin release following stimulation with intragastric instillation of a peptone solution in healthy probands and patients with duodenal ulcer].Zeitschrift fur Gastroenterologie, , Volume: 20, Issue:10, 1982
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.Scandinavian journal of gastroenterology. Supplement, , Volume: 66, 1980
Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.The Journal of clinical investigation, , Volume: 65, Issue:2, 1980
Intragastric titration of peptone-stimulated gastric acid secretion.Acta medica Academiae Scientiarum Hungaricae, , Volume: 35, Issue:2, 1978
Perfusion of the proximal small intestine with peptone stimulates gastric acid secretion in man.Gastroenterology, , Volume: 73, Issue:4 Pt 1, 1977
Effect of synthetic 15-methyl analog of PGE2 on gastric acid and serum gastrin response to peptone meal, pentagastrin, and histamine in duodenal ulcer patients.The American journal of digestive diseases, , Volume: 21, Issue:4, 1976
Serum gastrin and gastric acid responses to meals at various pH levels in man.Gut, , Volume: 15, Issue:7, 1974
Effect of metiamide, a histamine H2-receptor antagonist, on gastric response to histamine, pentagastrin, insulin, and peptone meal in man.The American journal of digestive diseases, , Volume: 19, Issue:7, 1974
Effect of atropine on gastrin and gastric acid response to peptone meal.The Journal of clinical investigation, , Volume: 54, Issue:3, 1974
Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.The New England journal of medicine, , Aug-22, Volume: 291, Issue:8, 1974
REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.Gut, , Volume: 5, 1964
Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH.Reviews of infectious diseases, , Volume: 13 Suppl 8
Evaluation of the impact of buffered peptone water composition on the discrimination between Salmonella enterica and Escherichia coli by Raman spectroscopy.Analytical and bioanalytical chemistry, , Volume: 412, Issue:15, 2020
Pet secretion, internalization and induction of cell death during infection of epithelial cells by enteroaggregative Escherichia coli.Microbiology (Reading, England), , Volume: 155, Issue:Pt 9, 2009
Anti-inflammatory evaluation of cryogenine.Journal of pharmaceutical sciences, , Volume: 56, Issue:11, 1967
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
Gonorrhoea as treated by pyrexia induced by peptone, a protein split product.Indian journal of venereal diseases and dermatology, , Volume: 13, Issue:4
Factors influencing the intestinal phase of pancreatic exocrine secretion in the turkey.Experientia, , Mar-15, Volume: 51, Issue:3, 1995
Duodenal lipid inhibits gastric acid secretion by vagal, capsaicin-sensitive afferent pathways in rats.The American journal of physiology, , Volume: 264, Issue:4 Pt 1, 1993
Effect of intraduodenal peptone on the lower esophageal sphincter pressure in the dog.Gastroenterology, , Volume: 75, Issue:2, 1978
Gastric and pancreatic responses to meals varying in pH.The Journal of physiology, , Volume: 243, Issue:1, 1974
Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs.Alimentary pharmacology & therapeutics, , Volume: 14, Issue:4, 2000
Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog.Gastroenterology, , Volume: 105, Issue:4, 1993
Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion.Regulatory peptides, , Nov-20, Volume: 42, Issue:1-2, 1992
Evidence for reflex adrenergic inhibition of acid secretion in the conscious rat.The American journal of physiology, , Volume: 251, Issue:5 Pt 1, 1986
Effects of antibodies to gastric inhibitory peptide on gastric acid secretion and gastrin release in the dog.Gastroenterology, , Volume: 84, Issue:5 Pt 1, 1983
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.Gastroenterology, , Volume: 68, Issue:6, 1975
Comparison of stimulants of antral release of gastrin.The American journal of physiology, , Volume: 215, Issue:2, 1968
MECHANISM OF ACTION OF PANCREATIC STIMULI STUDIED BY MEANS OF ATROPINELIKE DRUGS.The American journal of physiology, , Volume: 206, 1964
Some factors influencing the haemolysis of Bordetella bronchiseptica.Acta pathologica et microbiologica Scandinavica. Section B, Microbiology, , Volume: 84, Issue:2, 1976
[Some properties of carrier strains of Listeria monocytogenes (author's transl)].Medical microbiology and immunology, , Sep-19, Volume: 161, Issue:4, 1975
[The bacteriological diagnosis of Vibrio El Tor infection].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 212, Issue:1, 1969
[Observations on focal hemodestruction (Mueller's phenomenon) in staphylococci of various origin].Zhurnal mikrobiologii, epidemiologii i immunobiologii, , Volume: 43, Issue:3, 1966
Biotherapies of chronic diseases in the inter-war period: from Witte's peptone to Penicillium extract.Studies in history and philosophy of biological and biomedical sciences, , Volume: 36, Issue:4, 2005
[Immunization in allergic patients. 1].Medizinische Klinik, , Volume: 68, Issue:27, 1973
[Pathergy to humidity. Hydrogeological study of the Brussels region].Acta oto-rhino-laryngologica Belgica, , Volume: 26, Issue:4, 1972
[Side reactions of tetanus toxoid. I. Sensitizing ability of materials included in the medium].Nihon saikingaku zasshi. Japanese journal of bacteriology, , Volume: 24, Issue:8, 1969
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
[Role of the liver in peptone anaphylactic shock in dog].Acta gastro-enterologica Belgica, , Volume: 16, Issue:3, 1953
The effects of anaphylactic and peptone shock on the coagulability of rabbit and guinea-pig blood.The Journal of pharmacy and pharmacology, , Volume: 5, Issue:9, 1953
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
Formation of bradykinin in anaphylactic and peptone shock.The American journal of physiology, , Volume: 163, Issue:2, 1950
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides.The Journal of experimental medicine, , Volume: 90, Issue:1, 1949
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
[On cardiovascular effects of peptone in the rat].Archives internationales de physiologie et de biochimie, , Volume: 73, Issue:1, 1965
[ON ARTERIAL HYPERTENSION INDUCED BY PEPTONE IN RATS].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 158, 1964
[Comparative study of hypertensin, adrenalin and noradrenalin peptone shock].Archivos del Instituto de Farmacologia Experimental (Medicina), , Volume: 14, 1962
The effect of peptone shock on oliguric-hypertensive bladder reflex.Acta physiologica Polonica, , Volume: 26, Issue:1
A study of the bronchoconstrictor and hypotensive actions of curarizing drugs by Charles M. Landmesser.International anesthesiology clinics, ,Summer, Volume: 6, Issue:2, 1968
[On modes of stimulation of the rat adrenal medulla].Archives internationales de pharmacodynamie et de therapie, , Volume: 160, Issue:1, 1966
[On cardiovascular effects of peptone in the rat].Archives internationales de physiologie et de biochimie, , Volume: 73, Issue:1, 1965
[ROLE OF PLASMIN IN PEPTONE-INDUCED ARTERIAL HYPOTENSION IN RATS].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 158, 1964
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[Peptone shock in artificial hypothermia in dogs].Acta physiologica Polonica, , Volume: 8, Issue:4, 1957
[Modification of blood pressure in peptone shock in hypothermia in animals].Glasnik (Srpska akademija nauka), , Issue:9, 1955
[The course of peptone shock in artificial hypothermia in dogs].Archives internationales de pharmacodynamie et de therapie, , Volume: 117, Issue:3-4
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
Lipemia clearing in peptone and anaphylactic shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 89, Issue:2, 1955
The role played by leucocytes and platelets in anaphylactic and peptone shock.Annals of the New York Academy of Sciences, , Apr-28, Volume: 50, Issue:9, 1950
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum.Journal of leukocyte biology, , Volume: 77, Issue:3, 2005
Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model.Arthritis and rheumatism, , Volume: 32, Issue:5, 1989
A macrophage chemotaxis inhibitors produced by neoplasms: characterization of its biological activity.Advances in experimental medicine and biology, , Volume: 121B, 1979
Anti-inflammatory consequences of transplanted tumors.Advances in experimental medicine and biology, , Volume: 121B, 1979
The inflammatory response and resistance to endotoxin in mice.Journal of immunology (Baltimore, Md. : 1950), , Volume: 120, Issue:1, 1978
Cell-specific defect in monocyte function during tumor growth.Journal of the National Cancer Institute, , Volume: 57, Issue:1, 1976
Intraocular penetration of carbenicillin in the rabbit.American journal of ophthalmology, , Volume: 75, Issue:2, 1973
Ultrastructure of synovial membrane in pyogenic arthritis.Archives of pathology, , Volume: 96, Issue:3, 1973
Chemotaxis of leucocytes.Experientia, , Jul-15, Volume: 24, Issue:7, 1968
THE RELATION OF INFLAMMATION TO THE MOLECULAR STRUCTURE OF CARBON COMPOUNDS SOLUBLE IN THE FLUIDS OF THE BODY.The Journal of experimental medicine, , Apr-01, Volume: 121, 1965
Mononuclear phagocytic cells in peritoneal exudates of guinea pigs: a comparison of inducing agents.Allergologia et immunopathologia, , Volume: 13, Issue:6
Fibrinolytic activity of human "peptone-precipitated" plasma euglobulins.Thrombosis et diathesis haemorrhagica, , Jul-31, Volume: 19, Issue:3, 1968
Effect of citrovorum factor and peptones on mouse leukemia cells L-5178 in tissue culture.Science (New York, N.Y.), , Nov-15, Volume: 126, Issue:3281, 1957
Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.The Journal of clinical investigation, , Volume: 79, Issue:4, 1987
REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.Gut, , Volume: 5, 1964
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
Examinations on hepato-thyroidal correlations in liver lesion.Endokrinologie, , Volume: 57, Issue:3, 1971
[CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES].Revista clinica espanola, , Feb-15, Volume: 92, 1964
[The alkalimetric determination of the peptone-splitting effect of the blood serum in liver diseases and other diseases].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, , May-01, Volume: 14, Issue:9, 1959
[Splitting of peptones by blood serum in various diseases especially in liver diseases].Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, , Jun-15, Volume: 7, Issue:12, 1952
Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.Journal of immunology (Baltimore, Md. : 1950), , Volume: 127, Issue:1, 1981
Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.International journal of cancer, , Jun-15, Volume: 23, Issue:6, 1979
Evaluation of modified trypticase soy broth versus supplemented peptone broth in the detection of bacteremia and fungemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, , Volume: 7, Issue:3, 1988
Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia.Journal of clinical microbiology, , Volume: 21, Issue:4, 1985
Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 17, Issue:6, 1983
Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth.Journal of clinical microbiology, , Volume: 16, Issue:3, 1982
Production of ascospores by Piedraia hortai in vitro.Mycologia, , Volume: 63, Issue:3
[Relations between tumor growth and immunity].Schweizerische medizinische Wochenschrift, , Aug-19, Volume: 102, Issue:33, 1972
Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats.Lancet (London, England), , Oct-16, Volume: 2, Issue:7729, 1971
Employing Tryptone as a General Phase Transfer Agent to Produce Renal Clearable Nanodots for Bioimaging.Small (Weinheim an der Bergstrasse, Germany), , Aug-12, Volume: 11, Issue:30, 2015
Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.Acta microbiologica Hungarica, , Volume: 34, Issue:3-4, 1987
Differential expression of macrophage effector functions: bactericidal versus tumoricidal activities.Journal of leukocyte biology, , Volume: 36, Issue:3, 1984
Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.International journal of cancer, , Jun-15, Volume: 23, Issue:6, 1979
Macrophage processing of antigen for induction of tumor immunity.Cancer research, , Volume: 37, Issue:6, 1977
Promotion of tumor growth in vivo by antimacrophage agents.Journal of the National Cancer Institute, , Volume: 57, Issue:6, 1976
Cell-specific defect in monocyte function during tumor growth.Journal of the National Cancer Institute, , Volume: 57, Issue:1, 1976
ALPHA SARCIN, A NEW ANTITUMOR AGENT. II. FERMENTATION AND ANTITUMOR SPECTRUM.Applied microbiology, , Volume: 13, 1965
Effect of citrovorum factor and peptones on mouse leukemia cells L-5178 in tissue culture.Science (New York, N.Y.), , Nov-15, Volume: 126, Issue:3281, 1957
[Effect of peptone blocking asbestos-induced carcinogenesis in rats].Gigiena i sanitariia, , Issue:1
[The resistance of the causative organisms of actinomycosis and nocardiosis to some environmental factors. II. The survival in distilled water and in simple aqueous solutions].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 215, Issue:2, 1970
[The resistance of the causative organisms of actinomycosis and nocardiosis to some environmental factors. I. The resistance to ultraviolet rays].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 211, Issue:4, 1969
The effects of peptide-precipitating lignosulphonic acids on the proteolytic activity of pepsin in vitro and on the response of pigs to an ulcer inducing diet.Acta veterinaria Scandinavica, , Volume: 14, Issue:1, 1973
EFFECTS OF FREEZING ON THE GASTRIC MUCOSA OF DOGS.Gastroenterology, , Volume: 46, 1964
THE EFFECT OF CORTICOTROPIN ON THE ANTRAL PHASE OF GASTRIC SECRETION.JAMA, , Dec-14, Volume: 186, 1963
Structure and Anti-Inflammatory Activity of a New Unusual Fucosylated Chondroitin Sulfate from Marine drugs, , Oct-17, Volume: 16, Issue:10, 2018
No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse.International journal of hematology, , Volume: 100, Issue:2, 2014
Monomeric and multimeric blockers of selectins: comparison of in vitro and in vivo activity.Biochemistry. Biokhimiia, , Volume: 70, Issue:4, 2005
The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum.Journal of leukocyte biology, , Volume: 77, Issue:3, 2005
Fucoidan inhibits leukocyte recruitment in a model peritoneal inflammation in rat and blocks interaction of P-selectin with its carbohydrate ligand.Biochemistry and molecular biology international, , Volume: 43, Issue:2, 1997
[The influence of subphlogogenous thermal factors on the development of noninfectious inflammation in the peritoneum].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 60, Issue:10, 1965
[Experimental poliomyelitis and attempted treatment].Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, , Volume: 11, Issue:3, 1955
[Treatment of acute poliomyelitis].Annales medico-psychologiques, , Volume: 111, Issue:2 3, 1953
[Acute poliomyelitis and peptone shock].Revue medicale de la Suisse romande, , Volume: 73, Issue:7, 1953
Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis.Biological & pharmaceutical bulletin, , Volume: 18, Issue:1, 1995
Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.Immunology, , Volume: 57, Issue:2, 1986
Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.Cellular immunology, , Mar-01, Volume: 50, Issue:1, 1980
Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.Acta microbiologica Hungarica, , Volume: 34, Issue:3-4, 1987
Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.Journal of immunology (Baltimore, Md. : 1950), , Volume: 127, Issue:1, 1981
Macrophage-dependent, NK-cell-independent "natural" surveillance of tumors in syngeneic mice.International journal of cancer, , Jun-15, Volume: 23, Issue:6, 1979
Properties of the immunogenic and sensitizing activities of Bordetella pertussis in mice. I. Enhancement of peptone shock.The Journal of allergy, , Volume: 39, Issue:1, 1967
[On biocontrolled dosages in the therapy of experimental cardiovascular insufficiency].Kardiologiia, , Volume: 7, Issue:5, 1967
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. I. THE ROLE OF HISTAMINE IN ANAPHYLACTIC SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. II. THE ROLE OF HISTAMINE IN PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK OF THE DOG. IV. EFFECT OF HYPOTHERMIA ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
ANAPHYLACTIC SHOCK AND PEPTONE SHOCK IN THE DOG. III. EFFECT OF COMPOUND 48/80 ON ANAPHYLACTIC SHOCK AND PEPTONE SHOCK.Acta physiologica Academiae Scientiarum Hungaricae, , Volume: 23, 1963
[ON THE INFLUENCE OF HYPERTHERMIA ON THE COURSE OF EXPERIMENTAL SHOCK].Archives internationales de pharmacodynamie et de therapie, , Nov-01, Volume: 146, 1963
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[Comparative study of hypertensin, adrenalin and noradrenalin peptone shock].Archivos del Instituto de Farmacologia Experimental (Medicina), , Volume: 14, 1962
Production of peptone shock in mice following administration of H. pertussis vaccine.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 95, Issue:1, 1957
[Disorders of vascular permeability in shock; electrophoretic investigation of protein content of lymph in the development of peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 44, Issue:11, 1957
[Peptone shock in artificial hibernation in dogs].Acta physiologica Polonica, , Volume: 8, Issue:3-3a, 1957
[Peptone shock in artificial hypothermia in dogs].Acta physiologica Polonica, , Volume: 8, Issue:4, 1957
[Thrombin time and antithrombinic power of plasma during peptonic shock].Le Sang, , Volume: 27, Issue:9, 1956
[Modification of blood pressure in peptone shock in hypothermia in animals].Glasnik (Srpska akademija nauka), , Issue:9, 1955
[Experimental poliomyelitis and attempted treatment].Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, , Volume: 11, Issue:3, 1955
Release of histamine in hepatectomized dogs during anaphylactic, peptone and tryptic shock.Nature, , Oct-01, Volume: 176, Issue:4483, 1955
Activation of proteolytic enzymes in peptone shock in frogs.Archives internationales de pharmacodynamie et de therapie, , Oct-15, Volume: 103, Issue:4, 1955
Studies on the capillary permeability promoting action of serum. II. Significance of the serum CPPA in its relation to increased capillary permeability in anaphylaxis and peptone shock.The Tohoku journal of experimental medicine, , Nov-25, Volume: 62, Issue:4, 1955
[Capillary permeability in peptone shock; rate of disappearance of radioiodine-labeled protein from the blood in peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 38, Issue:11, 1954
New antiheparin agent: polybrene; effect in peptone shock and in experimental radiation injury.A.M.A. archives of surgery, , Volume: 66, Issue:4, 1953
The effects of anaphylactic and peptone shock on the coagulability of rabbit and guinea-pig blood.The Journal of pharmacy and pharmacology, , Volume: 5, Issue:9, 1953
[Acute poliomyelitis and peptone shock].Revue medicale de la Suisse romande, , Volume: 73, Issue:7, 1953
[Hepatic mastocytes in dog during peptone-induced shock].Acta haematologica, , Volume: 10, Issue:3, 1953
[Absence of modifications of hepatic mastocytes during peptone shock].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 147, Issue:9-10, 1953
[Effect of R.P. 4560 on peptone shock in the dog and the pig].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 147, Issue:19-20, 1953
Formation of bradykinin in anaphylactic and peptone shock.The American journal of physiology, , Volume: 163, Issue:2, 1950
[Modifications in the leukocyte formula and their origin during peptone shock].Algerie medicale, , Volume: 54, Issue:10, 1950
[Decrease of a peptone shock in the dog by combined action of atropine and a histamine antagonist].Comptes rendus des seances de la Societe de biologie et de ses filiales, , Volume: 144, Issue:5-6, 1950
Comparison of atropine and tripelennamine in treatment of peptone shock in dogs.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 70, Issue:2, 1949
Fibrinolysis in peptone shock.Federation proceedings, , Volume: 6, Issue:1 Pt 2, 1947
Activation of serum protease in peptone shock.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 66, Issue:2, 1947
Release of proteolytic enzyme in anaphylactic and peptone shock in vitro.Lancet (London, England), , May-24, Volume: 1, Issue:6456, 1947
Heredity of Rh blood types; improved nomenclature; additional family studies with special reference to Hr.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), , Volume: 61, 1946
Coagulation defect in the shocks produced by trypsin, peptone and ascaris extracts.Experimental medicine and surgery, , Volume: 4, 1946
On the thrombopenia of anaphylactic and peptone shock.The American journal of physiology, , Volume: 145, 1946
The behaviour of platelets in anaphylactic and peptone shock.Journal of immunology (Baltimore, Md. : 1950), , Volume: 52, 1946
Fibrinolysis in peptone and anaphylactic shock in the dog.Nature, , Jun-15, Volume: 157, 1946
[COMPARATIVE STUDIES ON THE BLOOD TRANSAMINASE ACTIVITY IN EXPERIMENTAL SHOCK. IV. GLUCAMIC-OXALOACETIC AND GLUTAMIC-PYRUVIC TRANSAMINASE ACTIVITY IN THE BLOOD SERUM IN INSULIN AND PEPTONE SHOCK].Acta physiologica Polonica, , Volume: 15
[On the problem of the course of peptone shock in radiation sickness].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Volume: 5
Influence of Ultracorten H on blood supply of the kidneys in peptone shock and in experimental injury of the heart with silver nitrate in rabbits.Materia medica Polona. Polish journal of medicine and pharmacy, , Volume: 7, Issue:4
[Effect of splanchnic nerve stimulation on the course of experimental shock].Acta physiologica Polonica, , Volume: 16, Issue:5
The effect of peptone shock on oliguric-hypertensive bladder reflex.Acta physiologica Polonica, , Volume: 26, Issue:1
[Electroencephalographic characteristics of peptone shock and its prevention with hydrocortisone].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Volume: 14, Issue:3
[The course of peptone shock in artificial hypothermia in dogs].Archives internationales de pharmacodynamie et de therapie, , Volume: 117, Issue:3-4
Peptone shock in the pertussissensitized mouse.The Journal of allergy, , Volume: 31
The influence of stimulation of the splanchnic nerves on the course of peptone shock in dogs deprived of the adrenal medullary substance.Acta medica Polona, , Volume: 9, Issue:1, 1968
[The course of experimental peptone shock with preliminary administration of desoxycorticosterone acetate (DOCA)].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 63, Issue:2, 1967
Peptonic and anaphylactic shock in the rat.Acta physiologica latino americana, , Volume: 15, Issue:4, 1965
[Permeability of the hemato-encephalitic barrier (HEB) for P32 in peptone shock].Biulleten' eksperimental'noi biologii i meditsiny, , Volume: 60, Issue:11, 1965
[THE ROLE OF HISTAMINE IN PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECTS OF HYPOTHERMIA ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
[EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].Kiserletes orvostudomany, , Volume: 15, 1963
Survival and biofilm formation by Group B streptococci in simulated vaginal fluid at different pHs.Antonie van Leeuwenhoek, , Volume: 101, Issue:3, 2012
[The antimicrobial action of potential thiol reagents].Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-hygienische Bakteriologie, Virusforschung und Parasitologie. Originale, , Volume: 14, Issue:4, 1970
Enhancement of mousevirulence of group A streptococci.Nature, , Nov-23, Volume: 180, Issue:4595, 1957
The effects of sodium sulfite on Helicobacter pylori by establishing a hypoxic environment.Toxicology and applied pharmacology, , 07-01, Volume: 470, 2023
Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.Alimentary pharmacology & therapeutics, , Volume: 14, Issue:6, 2000
Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.Alimentary pharmacology & therapeutics, , Volume: 10, Issue:6, 1996
Evaluation of three commercially available blood culture systems for cultivation of Helicobacter pylori.Journal of clinical microbiology, , Volume: 32, Issue:6, 1994
Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.Digestive diseases and sciences, , Volume: 38, Issue:9, 1993
Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects.Gastroenterology, , Volume: 102, Issue:4 Pt 1, 1992
Elevation of meal-stimulated gastrin release in subjects with Helicobacter pylori infection: reversal by low intragastric pH.Reviews of infectious diseases, , Volume: 13 Suppl 8
Safety/Toxicity (8)
| Article | Year |
|---|
Degradation and decolourization potential of ligninolytic enzyme producing Bacillus paramycoides BL2 and Micrococcus luteus BL3 for pulp paper industrial effluent and its toxicity evaluation.
Archives of microbiology, , Sep-26, Volume: 204, Issue:10 | 2022 |
Influence of acetylsalicylic acid on antibody-dependent cellular cytotoxicity (ADCC) of peritoneal macrophages.
Anticancer research, , Volume: 13, Issue:1 | |
In vitro toxicity evaluation of a product obtained from carmoisine using Tetrahymena pyriformis cells.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, , Volume: 31, Issue:10 | 1993 |
Gastric effects and side effects of synthetic secretin in man.
Regulatory peptides, , Volume: 2, Issue:4 | 1981 |
Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.
Immunology, , Volume: 57, Issue:2 | 1986 |
Effect of pH and organic matter on the toxicity of heavy metals to growth of some fungi.
Folia microbiologica, , Volume: 36, Issue:4 | 1991 |
Toxicity of oxalysine and oxalysine-containing peptides against Candida albicans: regulation of peptide transport by amino acids.
Journal of general microbiology, , Volume: 138, Issue:11 | 1992 |
Use of a macrophage cytotoxicity system to show macrophage activation by Listeria monocytogenes cell wall fraction.
Scandinavian journal of immunology, , Volume: 10, Issue:1 | 1979 |
Pharmacokinetics (2)
Bioavailability (5)
| Article | Year |
|---|
Bioconcentration of perfluoroalkyl substances by Chironomus plumosus larvae in water with different types of dissolved organic matters.
Environmental pollution (Barking, Essex : 1987), , Volume: 213 | 2016 |
Comparing humic substance and protein compound effects on the bioaccumulation of perfluoroalkyl substances by Daphnia magna in water.
Chemosphere, , Volume: 119 | 2015 |
Influence of single-walled carbon nanotubes on microbial availability of phenanthrene in sediment.
Ecotoxicology (London, England), , Volume: 20, Issue:6 | 2011 |
Supplementation of adjuvants for increasing the nutritive value and cell viability of probiotic fermented milk beverage.
International journal of food sciences and nutrition, , Volume: 60 Suppl 6 | 2009 |
Effects of nocloprost on gastric functions in man.
Scandinavian journal of gastroenterology, , Volume: 26, Issue:11 | 1991 |
Dosage (12)
| Article | Year |
|---|
How centrifugation influences the recovery and soy peptone incorporation in hyaluronic acid coils from fermentation.
Journal of biotechnology, , Nov-20, Volume: 341 | 2021 |
Optimization of xylanase production from Aspergillus niger for biobleaching of eucalyptus pulp.
Bioscience, biotechnology, and biochemistry, , Volume: 75, Issue:6 | 2011 |
Load-sensitive rat gastric vagal afferents encode volume but not gastric nutrients.
The American journal of physiology, , Volume: 274, Issue:2 | 1998 |
Gastric effects and side effects of synthetic secretin in man.
Regulatory peptides, , Volume: 2, Issue:4 | 1981 |
Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Scandinavian journal of gastroenterology. Supplement, , Volume: 66 | 1980 |
Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.
Gastroenterology, , Volume: 85, Issue:6 | 1983 |
Photoinhibition of growth in Acanthamoeba castellanii cultures.
Journal of bacteriology, , Volume: 103, Issue:3 | 1970 |
Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man.
European journal of clinical pharmacology, , Volume: 31, Issue:5 | 1987 |
Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.
The Journal of clinical investigation, , Volume: 79, Issue:4 | 1987 |
The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
Scandinavian journal of gastroenterology. Supplement, , Volume: 136 | 1987 |
[Changes in the antibacterial activity of nitrofurantoin preparations induced by peptone and hydrolysates].
Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Bacteriologia, virusologia, parazitologia, epidemiologia, , Volume: 34, Issue:2 | |
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
Gastroenterology, , Volume: 68, Issue:6 | 1975 |
Interactions (2)